activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1723378	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	=	Ki	nM	2500.0	CHEMBL4900	Homo sapiens	Ki	nM	2500.0
	1723378	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	=	Ki	nM	2500.0	CHEMBL4900	Homo sapiens	Ki	nM	2500.0
	1723483	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	9000.0	CHEMBL4900	Homo sapiens	Ki	nM	9000.0
	1723484	CHEMBL863189	Inhibition of Pkd2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	9000.0	CHEMBL4900	Homo sapiens	Ki	nM	9000.0
	1723485	CHEMBL863189	Inhibition of Pkd2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	=	Ki	nM	950.0	CHEMBL4900	Homo sapiens	Ki	nM	950.0
	1723486	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	9000.0	CHEMBL4900	Homo sapiens	Ki	nM	9000.0
	1723487	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Ki	nM	5300.0	CHEMBL4900	Homo sapiens	Ki	nM	5300.0
	1723798	CHEMBL863189	Inhibition of Pkd2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Ki	nM	5300.0	CHEMBL4900	Homo sapiens	Ki	nM	5300.0
	1727578	CHEMBL859767	Inhibition of human PKD2 at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	-7.0	CHEMBL4900	Homo sapiens	Inhibition	%	-7.0
	1734101	CHEMBL862828	Residual activity at human PKD2 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	91.0	CHEMBL4900	Homo sapiens	Activity	%	91.0
	1744392	CHEMBL866668	Inhibition of Pkd2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	=	Ki	nM	5200.0	CHEMBL4900	Homo sapiens	Ki	uM	5.2
	1769437	CHEMBL910945	Inhibition of PKD2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4900	Homo sapiens	IC50	uM	1.0
	1790070	CHEMBL855331	Percentage activity of human PKD2 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	95.0	CHEMBL4900	Homo sapiens	Activity	%	95.0
	1824596	CHEMBL915362	Inhibition of Pkd2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	Ki	uM	10.0
	1824664	CHEMBL915362	Inhibition of Pkd2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	Ki	uM	10.0
	1824754	CHEMBL915362	Inhibition of Pkd2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	Ki	uM	10.0
	2025207	CHEMBL887015	Inhibition of human PKD2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	97.0	CHEMBL4900	Homo sapiens	Inhibition	%	97.0
	2025513	CHEMBL887015	Inhibition of human PKD2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	100.0	CHEMBL4900	Homo sapiens	Inhibition	%	100.0
	2025514	CHEMBL887015	Inhibition of human PKD2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	115.0	CHEMBL4900	Homo sapiens	Inhibition	%	115.0
	2025515	CHEMBL887015	Inhibition of human PKD2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	103.0	CHEMBL4900	Homo sapiens	Inhibition	%	103.0
	2051669	CHEMBL941805	Inhibition of PKD2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	8980.0	CHEMBL4900	Homo sapiens	Ki	uM	8.98
	2147363	CHEMBL922148	Activity of human PKD2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	90.0	CHEMBL4900	Homo sapiens	Activity	%	90.0
	2248283	CHEMBL1012716	Inhibition of PKD2 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	-6.0	CHEMBL4900	Homo sapiens	INH	%	-6.0
	2248284	CHEMBL1012716	Inhibition of PKD2 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	-3.0	CHEMBL4900	Homo sapiens	INH	%	-3.0
	2251068	CHEMBL1011943	Inhibition of PKD2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	37.0	CHEMBL4900	Homo sapiens	INH	%	37.0
	2356987	CHEMBL958283	Inhibition of PKD2 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	2470323	CHEMBL992500	Inhibition of PRKD2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4900	Homo sapiens	INH	%	10.0
	2567275	CHEMBL975462	Inhibition of human PKD2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	105.0	CHEMBL4900	Homo sapiens	Activity	%	105.0
	2721699	CHEMBL1054324	Inhibition of PKD2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	2906319	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906320	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906321	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	950.0	CHEMBL4900	Homo sapiens	Kd	nM	950.0
	2906322	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906323	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906324	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	3900.0	CHEMBL4900	Homo sapiens	Kd	nM	3900.0
	2906325	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906326	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906327	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906328	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906329	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906330	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906331	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906332	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906333	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1100.0	CHEMBL4900	Homo sapiens	Kd	nM	1100.0
	2906334	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906335	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906336	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906337	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906338	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906339	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906340	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	890.0	CHEMBL4900	Homo sapiens	Kd	nM	890.0
	2906341	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906342	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906343	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906344	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	6300.0	CHEMBL4900	Homo sapiens	Kd	nM	6300.0
	2906345	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906346	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906347	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906348	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906349	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906350	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906351	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	72.0	CHEMBL4900	Homo sapiens	Kd	nM	72.0
	2906352	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3700.0	CHEMBL4900	Homo sapiens	Kd	nM	3700.0
	2906353	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL4900	Homo sapiens	Kd	nM	380.0
	2906354	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906355	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2906356	CHEMBL1061156	Binding constant for PRKD2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	2921194	CHEMBL1058404	Inhibition of PRKD2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	2938452	CHEMBL1041413	Inhibition of PRKD2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
Not Active	2938590	CHEMBL1040603	Inhibition of PKD2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	3052459	CHEMBL1072497	Residual activity of PRKD2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL4900	Homo sapiens	Residual activity	%	95.0
	3052711	CHEMBL1042974	Residual activity of PRKD2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL4900	Homo sapiens	Residual activity	%	90.0
	3054020	CHEMBL1071350	Residual activity of PRKD2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	128.0	CHEMBL4900	Homo sapiens	Residual activity	%	128.0
	3054272	CHEMBL1072497	Residual activity of PRKD2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	82.0	CHEMBL4900	Homo sapiens	Residual activity	%	82.0
	3055559	CHEMBL1042974	Residual activity of PRKD2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	82.0	CHEMBL4900	Homo sapiens	Residual activity	%	82.0
	3056864	CHEMBL1071350	Residual activity of PRKD2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	146.0	CHEMBL4900	Homo sapiens	Residual activity	%	146.0
	3057116	CHEMBL1072497	Residual activity of PRKD2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	89.0	CHEMBL4900	Homo sapiens	Residual activity	%	89.0
	3058436	CHEMBL1042974	Residual activity of PRKD2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL4900	Homo sapiens	Residual activity	%	94.0
	3059720	CHEMBL1071350	Residual activity of PRKD2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	136.0	CHEMBL4900	Homo sapiens	Residual activity	%	136.0
	3084398	CHEMBL1072677	Inhibition of PKD2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	950.0	CHEMBL4900	Homo sapiens	IC50	uM	0.95
	3094763	CHEMBL1069036	Inhibition of PKD2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	3094784	CHEMBL1069036	Inhibition of PKD2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	3094795	CHEMBL1069036	Inhibition of PKD2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	16.0	CHEMBL4900	Homo sapiens	INH	%	16.0
	3094811	CHEMBL1069036	Inhibition of PKD2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	26.0	CHEMBL4900	Homo sapiens	INH	%	26.0
	3214024	CHEMBL1103219	Inhibition of PKD2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	9.0	CHEMBL4900	Homo sapiens	INH	%	9.0
	3219700	CHEMBL1111351	Inhibition of PKD2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	79.0	CHEMBL4900	Homo sapiens	INH	%	79.0
	3224938	CHEMBL1101491	Inhibition of PKD2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3226317	CHEMBL1101491	Inhibition of PKD2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3240832	CHEMBL1109675	Inhibition of PKD2	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL4900	Homo sapiens	IC50	uM	1.0
	3261182	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	7.0	CHEMBL4900	Homo sapiens	INH	%	7.0
	3261183	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	3261184	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
Not Determined	3261185	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	3261186	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	3261187	CHEMBL1112583	Inhibition of PKD2 at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	11.0	CHEMBL4900	Homo sapiens	INH	%	11.0
Not Active	3272500	CHEMBL1108317	Inhibition of PKD2	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272501	CHEMBL1108317	Inhibition of PKD2	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272502	CHEMBL1108317	Inhibition of PKD2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272503	CHEMBL1108317	Inhibition of PKD2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272504	CHEMBL1108317	Inhibition of PKD2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272505	CHEMBL1108317	Inhibition of PKD2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272506	CHEMBL1108317	Inhibition of PKD2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272507	CHEMBL1108317	Inhibition of PKD2	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272508	CHEMBL1108317	Inhibition of PKD2	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3272509	CHEMBL1108317	Inhibition of PKD2	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	3272510	CHEMBL1108317	Inhibition of PKD2	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL4900	Homo sapiens	INH	%	20.0
Not Active	3272511	CHEMBL1108317	Inhibition of PKD2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	3332115	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3333530	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3334935	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3336355	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3337629	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3338960	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3339214	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3340517	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3341897	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3343344	CHEMBL1166826	Inhibition of PRKD2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	3354250	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	85.0	CHEMBL4900	Homo sapiens	INH	%	85.0
	3354329	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1	Outside typical range	CHEMBL1170750	=	Inhibition	%	-14.0	CHEMBL4900	Homo sapiens	INH	%	-14.0
	3354330	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	3354331	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	-6.0	CHEMBL4900	Homo sapiens	INH	%	-6.0
	3354332	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	11.0	CHEMBL4900	Homo sapiens	INH	%	11.0
	3354333	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	3354334	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	26.0	CHEMBL4900	Homo sapiens	INH	%	26.0
	3354335	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	3354336	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	55.0	CHEMBL4900	Homo sapiens	INH	%	55.0
	3354337	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	53.0	CHEMBL4900	Homo sapiens	INH	%	53.0
	3354338	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	3354339	CHEMBL1173982	Inhibition of PKD2 at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	10.0	CHEMBL4900	Homo sapiens	INH	%	10.0
	3358770	CHEMBL1175236	Inhibition of PRKD2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	56.0	CHEMBL4900	Homo sapiens	INH	%	56.0
	3359212	CHEMBL1175236	Inhibition of PRKD2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	13.0	CHEMBL4900	Homo sapiens	INH	%	13.0
	3400037	CHEMBL1217234	Inhibition of human PKD2 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	77.0	CHEMBL4900	Homo sapiens	INH	%	77.0
	3407876	CHEMBL1219829	Inhibition of PKD2 ( assessed as residual activity at 1 uM ) by TR-FRET assay	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	7.0	CHEMBL4900	Homo sapiens	Activity	%	7.0
	3408960	CHEMBL1219829	Inhibition of PKD2 ( assessed as residual activity at 1 uM ) by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	2.0	CHEMBL4900	Homo sapiens	IC50	nM	2.0
	3408961	CHEMBL1219829	Inhibition of PKD2 ( assessed as residual activity at 1 uM ) by TR-FRET assay	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	IC50	nM	16.0	CHEMBL4900	Homo sapiens	IC50	nM	16.0
	3409063	CHEMBL1219829	Inhibition of PKD2 ( assessed as residual activity at 1 uM ) by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	2.0	CHEMBL4900	Homo sapiens	Activity	%	2.0
	3409097	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	IC50	nM	9.0	CHEMBL4900	Homo sapiens	IC50	nM	9.0
	3409098	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215000	=	IC50	nM	1.0	CHEMBL4900	Homo sapiens	IC50	nM	1.0
	3409099	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCOCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215001	=	IC50	nM	9.0	CHEMBL4900	Homo sapiens	IC50	nM	9.0
	3409100	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	CC(C)Nc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215002	=	IC50	nM	8.0	CHEMBL4900	Homo sapiens	IC50	nM	8.0
	3409101	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	Cn1ccc(Nc2cc(-c3cc(C(N)=O)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215074	=	IC50	nM	7.0	CHEMBL4900	Homo sapiens	IC50	nM	7.0
	3409102	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3Cl)c2)nc(N2CCNCC2)c1		CHEMBL1215075	=	IC50	nM	8.0	CHEMBL4900	Homo sapiens	IC50	nM	8.0
	3409103	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215076	=	IC50	nM	59.0	CHEMBL4900	Homo sapiens	IC50	nM	59.0
	3409104	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	CCNc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215077	=	IC50	nM	31.0	CHEMBL4900	Homo sapiens	IC50	nM	31.0
	3409105	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	N#Cc1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215078	=	IC50	nM	130.0	CHEMBL4900	Homo sapiens	IC50	nM	130.0
	3409106	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	N#Cc1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215149	=	IC50	nM	35.0	CHEMBL4900	Homo sapiens	IC50	nM	35.0
	3409107	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	Cn1ccc(Nc2cc(-c3cc(C#N)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215150	=	IC50	nM	68.0	CHEMBL4900	Homo sapiens	IC50	nM	68.0
	3409108	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215151	=	IC50	nM	1.0	CHEMBL4900	Homo sapiens	IC50	nM	1.0
	3409109	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	c1cc(-c2cc(-c3cc[nH]n3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215152	=	IC50	nM	62.0	CHEMBL4900	Homo sapiens	IC50	nM	62.0
	3409110	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	CC(C)Nc1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)ccn1		CHEMBL1215153	=	IC50	nM	2.0	CHEMBL4900	Homo sapiens	IC50	nM	2.0
	3409111	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCOCC2)n1		CHEMBL1215219	=	IC50	nM	2.0	CHEMBL4900	Homo sapiens	IC50	nM	2.0
	3409112	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(N[C@@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215220	=	IC50	nM	18.0	CHEMBL4900	Homo sapiens	IC50	nM	18.0
	3409113	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(N[C@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215221	=	IC50	nM	540.0	CHEMBL4900	Homo sapiens	IC50	nM	540.0
	3409114	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	C[C@@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215222	=	IC50	nM	60.0	CHEMBL4900	Homo sapiens	IC50	nM	60.0
	3409115	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	C[C@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215223	=	IC50	nM	86.0	CHEMBL4900	Homo sapiens	IC50	nM	86.0
	3409116	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCCC(N)C2)c1		CHEMBL1215285	=	IC50	nM	168.0	CHEMBL4900	Homo sapiens	IC50	nM	168.0
	3409117	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	CN1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215286	=	IC50	nM	238.0	CHEMBL4900	Homo sapiens	IC50	nM	238.0
	3409118	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	NCC1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215287	=	IC50	nM	212.0	CHEMBL4900	Homo sapiens	IC50	nM	212.0
	3409119	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	CC1(C)CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215288	=	IC50	nM	427.0	CHEMBL4900	Homo sapiens	IC50	nM	427.0
	3409120	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	FC(F)(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215360	=	IC50	nM	101.0	CHEMBL4900	Homo sapiens	IC50	nM	101.0
	3409121	CHEMBL1219873	Inhibition of PKD2 by TR-FRET assay	B	FC(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215361	=	IC50	nM	76.0	CHEMBL4900	Homo sapiens	IC50	nM	76.0
	3443502	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	28.0	CHEMBL4900	Homo sapiens	INH	%	28.0
	3443719	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	89.0	CHEMBL4900	Homo sapiens	INH	%	89.0
	3444874	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	81.0	CHEMBL4900	Homo sapiens	INH	%	81.0
	3445269	CHEMBL1244941	Binding affinity to PRKD2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	8.1	CHEMBL4900	Homo sapiens	Kd	nM	8.1
	3445498	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	13.0	CHEMBL4900	Homo sapiens	INH	%	13.0
	3445715	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	9.0	CHEMBL4900	Homo sapiens	INH	%	9.0
	3445910	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	31.0	CHEMBL4900	Homo sapiens	INH	%	31.0
	3446100	CHEMBL1244268	Inhibition of PRKD2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	71.0	CHEMBL4900	Homo sapiens	INH	%	71.0
	3448042	CHEMBL1249683	Inhibition of human PKD2 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	55.0	CHEMBL4900	Homo sapiens	INH	%	55.0
	3448118	CHEMBL1249683	Inhibition of human PKD2 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	11.0	CHEMBL4900	Homo sapiens	INH	%	11.0
	3448588	CHEMBL1244941	Binding affinity to PRKD2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	3449022	CHEMBL1244941	Binding affinity to PRKD2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	6300.0	CHEMBL4900	Homo sapiens	Kd	nM	6300.0
	3449312	CHEMBL1244941	Binding affinity to PRKD2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL4900	Homo sapiens	Kd	nM	380.0
	3449819	CHEMBL1244941	Binding affinity to PRKD2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	3450213	CHEMBL1244941	Binding affinity to PRKD2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	3451125	CHEMBL1244941	Binding affinity to PRKD2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	uM	10.0
	3463335	CHEMBL1251595	Inhibition of PRKD2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	98.0	CHEMBL4900	Homo sapiens	INH	%	98.0
	3463879	CHEMBL1251595	Inhibition of PRKD2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	INH	%	4.0
	3464098	CHEMBL1251595	Inhibition of PRKD2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	76.0	CHEMBL4900	Homo sapiens	INH	%	76.0
Active	3564129	CHEMBL1285299	Inhibition of PKD2 at 0.1 uM	B	NC(=O)c1cccc(CNC(=O)c2cc3c(c4c2[nH]c2ccccc24)C(=O)NC3=O)c1		CHEMBL1278026		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	3599530	CHEMBL1291146	Displacement of radiolabeled MAPKAPK from PKD2 at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL4900	Homo sapiens	Activity		
	5120439	CHEMBL1648688	Inhibition of human PKD2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	110.0	CHEMBL4900	Homo sapiens	INH	%	110.0
	5123938	CHEMBL1647699	Inhibition of PKD at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	5206207	CHEMBL1671209	Inhibition of PKD2 at 10 uM	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1222990	=	Inhibition	%	90.0	CHEMBL4900	Homo sapiens	INH	%	90.0
	5206208	CHEMBL1671210	Inhibition of PKD3 at 0.2 uM	B	O=C(NC[C@@H]1C[C@@H](F)CN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1669329	=	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	5220295	CHEMBL1681588	Inhibition of human recombinant PKD2 after 10 mins by radiometric assay	B	O=C1NCCCc2c1oc1ccc(O)cc21		CHEMBL1450770	=	IC50	nM	280.0	CHEMBL4900	Homo sapiens	IC50	nM	280.0
	5220296	CHEMBL1681588	Inhibition of human recombinant PKD2 after 10 mins by radiometric assay	B	COc1ncc2sc3c(c2n1)SCCNC3=O		CHEMBL1672575	=	IC50	nM	50.0	CHEMBL4900	Homo sapiens	IC50	nM	50.0
	5223299	CHEMBL1679289	Binding affinity to PKD2 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL4900	Homo sapiens	INH	%	90.0
	5235545	CHEMBL1686346	Inhibition of human PKD2	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	IC50	nM	48.0	CHEMBL4900	Homo sapiens	IC50	uM	0.048
	5235547	CHEMBL1686348	Inhibition of human PKD2 at 1 uM	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	Inhibition	%	85.0	CHEMBL4900	Homo sapiens	INH	%	85.0
	5243756	CHEMBL1685860	Inhibition of PKD2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	93.0	CHEMBL4900	Homo sapiens	INH	%	93.0
	5243864	CHEMBL1686076	Inhibition of PKD2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	5243977	CHEMBL1685860	Inhibition of PKD2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	41.0	CHEMBL4900	Homo sapiens	INH	%	41.0
	5244085	CHEMBL1686076	Inhibition of PKD2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	12.0	CHEMBL4900	Homo sapiens	INH	%	12.0
	5244958	CHEMBL1685860	Inhibition of PKD2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	107.0	CHEMBL4900	Homo sapiens	INH	%	107.0
	5245066	CHEMBL1686076	Inhibition of PKD2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	110.0	CHEMBL4900	Homo sapiens	INH	%	110.0
	5245217	CHEMBL1685860	Inhibition of PKD2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	113.0	CHEMBL4900	Homo sapiens	INH	%	113.0
	5246047	CHEMBL1686076	Inhibition of PKD2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	107.0	CHEMBL4900	Homo sapiens	INH	%	107.0
	6315166	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	INH	%	-1.0
	6315167	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	26.0	CHEMBL4900	Homo sapiens	INH	%	26.0
	6315168	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	33.0	CHEMBL4900	Homo sapiens	INH	%	33.0
	6315169	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	29.0	CHEMBL4900	Homo sapiens	INH	%	29.0
	6315170	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	6315171	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	28.0	CHEMBL4900	Homo sapiens	INH	%	28.0
	6315172	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	6315173	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315174	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1	Outside typical range	CHEMBL1813613	=	Inhibition	%	-15.0	CHEMBL4900	Homo sapiens	INH	%	-15.0
	6315175	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	6315176	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	-6.0	CHEMBL4900	Homo sapiens	INH	%	-6.0
	6315177	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	-7.0	CHEMBL4900	Homo sapiens	INH	%	-7.0
	6315178	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	6315179	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1	Outside typical range	CHEMBL1813619	=	Inhibition	%	-11.0	CHEMBL4900	Homo sapiens	INH	%	-11.0
	6315180	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315181	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	6315182	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	6315183	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	36.0	CHEMBL4900	Homo sapiens	INH	%	36.0
	6315184	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	25.0	CHEMBL4900	Homo sapiens	INH	%	25.0
	6315185	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	34.0	CHEMBL4900	Homo sapiens	INH	%	34.0
	6315186	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315187	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	21.0	CHEMBL4900	Homo sapiens	INH	%	21.0
	6315188	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	-4.0	CHEMBL4900	Homo sapiens	INH	%	-4.0
	6315189	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	9.0	CHEMBL4900	Homo sapiens	INH	%	9.0
	6315190	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	6315191	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	6315192	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	13.0	CHEMBL4900	Homo sapiens	INH	%	13.0
	6315193	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	16.0	CHEMBL4900	Homo sapiens	INH	%	16.0
	6315194	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	-4.0	CHEMBL4900	Homo sapiens	INH	%	-4.0
	6315195	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	6315196	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	INH	%	4.0
	6315197	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	6315198	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	INH	%	-1.0
	6315199	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	INH	%	-1.0
	6315200	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	6315201	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	6315202	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	6315203	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	20.0	CHEMBL4900	Homo sapiens	INH	%	20.0
	6315204	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	28.0	CHEMBL4900	Homo sapiens	INH	%	28.0
	6315205	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	6315206	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	16.0	CHEMBL4900	Homo sapiens	INH	%	16.0
	6315207	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315208	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	-3.0	CHEMBL4900	Homo sapiens	INH	%	-3.0
	6315209	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	6315210	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315211	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	-3.0	CHEMBL4900	Homo sapiens	INH	%	-3.0
	6315212	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1	Outside typical range	CHEMBL1813802	=	Inhibition	%	-11.0	CHEMBL4900	Homo sapiens	INH	%	-11.0
	6315213	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	25.0	CHEMBL4900	Homo sapiens	INH	%	25.0
	6315214	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1	Outside typical range	CHEMBL1813804	=	Inhibition	%	-30.0	CHEMBL4900	Homo sapiens	INH	%	-30.0
	6315215	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	6315216	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	6315217	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	6.0	CHEMBL4900	Homo sapiens	INH	%	6.0
	6315218	CHEMBL1815695	Inhibition of PKD2 at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	83.0	CHEMBL4900	Homo sapiens	INH	%	83.0
	6340950	CHEMBL1827274	Activity of PRKD2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	93.0	CHEMBL4900	Homo sapiens	Activity	%	93.0
	6385563	CHEMBL1837946	Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	6385564	CHEMBL1837946	Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	6385565	CHEMBL1837946	Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	6385566	CHEMBL1837946	Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	6385567	CHEMBL1837946	Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	7567519	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7567990	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	1100.0	CHEMBL4900	Homo sapiens	Kd	nM	1100.0
	7568458	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7568890	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3700.0	CHEMBL4900	Homo sapiens	Kd	nM	3700.0
	7569033	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7569493	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7569965	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7570428	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7570855	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	380.0	CHEMBL4900	Homo sapiens	Kd	nM	380.0
	7571009	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7571466	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7571942	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7572405	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7572821	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	160.0	CHEMBL4900	Homo sapiens	Kd	nM	160.0
	7572990	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	510.0	CHEMBL4900	Homo sapiens	Kd	nM	510.0
	7573447	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7573923	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	320.0	CHEMBL4900	Homo sapiens	Kd	nM	320.0
	7574968	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	720.0	CHEMBL4900	Homo sapiens	Kd	nM	720.0
	7575429	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7575900	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7575923	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	6300.0	CHEMBL4900	Homo sapiens	Kd	nM	6300.0
	7576331	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7576942	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7577401	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7577907	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7578312	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7578950	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7579324	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7579806	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1500.0	CHEMBL4900	Homo sapiens	Kd	nM	1500.0
	7580275	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7580678	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7581696	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1100.0	CHEMBL4900	Homo sapiens	Kd	nM	1100.0
	7582167	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7582631	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7583031	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7583212	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7583609	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7584054	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7584525	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7584987	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7585391	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7585542	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7585950	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	3900.0	CHEMBL4900	Homo sapiens	Kd	nM	3900.0
	7586396	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7586867	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	890.0	CHEMBL4900	Homo sapiens	Kd	nM	890.0
	7587321	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7587503	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7587922	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7588375	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7588846	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7589297	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7589468	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7589892	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	8.1	CHEMBL4900	Homo sapiens	Kd	nM	8.1
	7590359	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7590833	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7591441	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7591863	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7592335	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7592819	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7593408	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	950.0	CHEMBL4900	Homo sapiens	Kd	nM	950.0
	7593843	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7594346	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7594798	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7595376	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7595820	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7595852	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7596323	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7596770	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7597348	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7597832	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7598302	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4900	Homo sapiens	Kd	nM	10000.0
	7598744	CHEMBL1908799	Binding constant for PRKD2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	72.0	CHEMBL4900	Homo sapiens	Kd	nM	72.0
	7922701	CHEMBL1919018	Inhibition of human recombinant PRKD2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	7939953	CHEMBL1919622	Inhibition of human PKD2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	uM	10.0
	7961127	CHEMBL1931545	Inhibition of PKD2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4900	Homo sapiens	IC50	uM	30.0
	7961128	CHEMBL1931545	Inhibition of PKD2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4900	Homo sapiens	IC50	uM	30.0
	7971377	CHEMBL1929905	Inhibition of PKD2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	7989383	CHEMBL1937077	Inhibition of human PRKD2	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	139.0	CHEMBL4900	Homo sapiens	IC50	nM	139.0
Active	7996848	CHEMBL1941736	Inhibition of PKD2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	7996849	CHEMBL1941736	Inhibition of PKD2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	7996850	CHEMBL1941736	Inhibition of PKD2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	7996851	CHEMBL1941736	Inhibition of PKD2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	8018885	CHEMBL1949057	Inhibition of PKD2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	94.0	CHEMBL4900	Homo sapiens	Activity	%	94.0
Not Determined	8018886	CHEMBL1949057	Inhibition of PKD2 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950		Activity			CHEMBL4900	Homo sapiens	Activity		
Not Determined	8018887	CHEMBL1949057	Inhibition of PKD2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262		Activity			CHEMBL4900	Homo sapiens	Activity		
	8061238	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.57	CHEMBL4900	Homo sapiens	Inhibition	%	1.57
	8061415	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	Inhibition	%	1.0
	8061639	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.47	CHEMBL4900	Homo sapiens	Inhibition	%	2.47
	8061746	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	46.48	CHEMBL4900	Homo sapiens	Inhibition	%	46.48
	8061937	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.33	CHEMBL4900	Homo sapiens	Inhibition	%	3.33
	8062161	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.92	CHEMBL4900	Homo sapiens	Inhibition	%	9.92
	8062277	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.42	CHEMBL4900	Homo sapiens	Inhibition	%	2.42
	8062663	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.14	CHEMBL4900	Homo sapiens	Inhibition	%	6.14
	8062761	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.25	CHEMBL4900	Homo sapiens	Inhibition	%	3.25
	8062985	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.79	CHEMBL4900	Homo sapiens	Inhibition	%	0.79
	8063117	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.23	CHEMBL4900	Homo sapiens	Inhibition	%	4.23
	8063508	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.34	CHEMBL4900	Homo sapiens	Inhibition	%	4.34
	8063616	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.87	CHEMBL4900	Homo sapiens	Inhibition	%	2.87
	8064022	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.98	CHEMBL4900	Homo sapiens	Inhibition	%	5.98
	8064137	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.43	CHEMBL4900	Homo sapiens	Inhibition	%	10.43
	8064361	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.81	CHEMBL4900	Homo sapiens	Inhibition	%	1.81
	8064571	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.06	CHEMBL4900	Homo sapiens	Inhibition	%	5.06
	8064709	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.6	CHEMBL4900	Homo sapiens	Inhibition	%	0.6
	8064933	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.42	CHEMBL4900	Homo sapiens	Inhibition	%	3.42
	8065099	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.92	CHEMBL4900	Homo sapiens	Inhibition	%	1.92
	8065215	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.06	CHEMBL4900	Homo sapiens	Inhibition	%	6.06
	8065439	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.58	CHEMBL4900	Homo sapiens	Inhibition	%	4.58
	8065614	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	48.97	CHEMBL4900	Homo sapiens	Inhibition	%	48.97
	8065953	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	5.77	CHEMBL4900	Homo sapiens	Inhibition	%	5.77
	8066163	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.51	CHEMBL4900	Homo sapiens	Inhibition	%	1.51
	8066523	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.57	CHEMBL4900	Homo sapiens	Inhibition	%	2.57
	8066689	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.69	CHEMBL4900	Homo sapiens	Inhibition	%	1.69
	8067037	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.58	CHEMBL4900	Homo sapiens	Inhibition	%	4.58
	8067212	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.66	CHEMBL4900	Homo sapiens	Inhibition	%	2.66
	8067557	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.93	CHEMBL4900	Homo sapiens	Inhibition	%	1.93
	8067767	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.17	CHEMBL4900	Homo sapiens	Inhibition	%	3.17
	8068126	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	15.89	CHEMBL4900	Homo sapiens	Inhibition	%	15.89
	8068290	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.97	CHEMBL4900	Homo sapiens	Inhibition	%	1.97
	8068639	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.3	CHEMBL4900	Homo sapiens	Inhibition	%	3.3
	8068813	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.37	CHEMBL4900	Homo sapiens	Inhibition	%	5.37
	8069037	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.94	CHEMBL4900	Homo sapiens	Inhibition	%	3.94
	8069162	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.87	CHEMBL4900	Homo sapiens	Inhibition	%	5.87
	8069457	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	22.24	CHEMBL4900	Homo sapiens	Inhibition	%	22.24
	8069618	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.25	CHEMBL4900	Homo sapiens	Inhibition	%	2.25
	8069842	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.28	CHEMBL4900	Homo sapiens	Inhibition	%	2.28
	8069968	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.16	CHEMBL4900	Homo sapiens	Inhibition	%	2.16
	8070364	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.99	CHEMBL4900	Homo sapiens	Inhibition	%	4.99
	8070489	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.16	CHEMBL4900	Homo sapiens	Inhibition	%	1.16
	8070713	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	10.94	CHEMBL4900	Homo sapiens	Inhibition	%	10.94
	8070787	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	81.04	CHEMBL4900	Homo sapiens	Inhibition	%	81.04
	8071168	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.34	CHEMBL4900	Homo sapiens	Inhibition	%	2.34
	8071294	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	5.63	CHEMBL4900	Homo sapiens	Inhibition	%	5.63
	8071518	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	46.92	CHEMBL4900	Homo sapiens	Inhibition	%	46.92
	8071691	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	Inhibition	%	3.0
	8072040	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.61	CHEMBL4900	Homo sapiens	Inhibition	%	-0.61
	8072130	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.66	CHEMBL4900	Homo sapiens	Inhibition	%	0.66
	8072354	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.8	CHEMBL4900	Homo sapiens	Inhibition	%	1.8
	8072511	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.3	CHEMBL4900	Homo sapiens	Inhibition	%	2.3
	8072860	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.09	CHEMBL4900	Homo sapiens	Inhibition	%	1.09
	8073027	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.03	CHEMBL4900	Homo sapiens	Inhibition	%	5.03
	8073376	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.09	CHEMBL4900	Homo sapiens	Inhibition	%	1.09
	8073495	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.62	CHEMBL4900	Homo sapiens	Inhibition	%	1.62
	8073719	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.97	CHEMBL4900	Homo sapiens	Inhibition	%	1.97
	8073952	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.71	CHEMBL4900	Homo sapiens	Inhibition	%	1.71
	8074104	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.45	CHEMBL4900	Homo sapiens	Inhibition	%	2.45
	8074458	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.88	CHEMBL4900	Homo sapiens	Inhibition	%	1.88
	8074615	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.63	CHEMBL4900	Homo sapiens	Inhibition	%	4.63
	8074839	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	9.53	CHEMBL4900	Homo sapiens	Inhibition	%	9.53
	8074966	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.68	CHEMBL4900	Homo sapiens	Inhibition	%	0.68
	8075301	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.15	CHEMBL4900	Homo sapiens	Inhibition	%	2.15
	8075538	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	6.86	CHEMBL4900	Homo sapiens	Inhibition	%	6.86
	8075679	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.1	CHEMBL4900	Homo sapiens	Inhibition	%	3.1
	8075903	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.62	CHEMBL4900	Homo sapiens	Inhibition	%	3.62
	8076045	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.18	CHEMBL4900	Homo sapiens	Inhibition	%	2.18
	8076417	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.79	CHEMBL4900	Homo sapiens	Inhibition	%	3.79
	8076551	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.37	CHEMBL4900	Homo sapiens	Inhibition	%	4.37
	8076877	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.09	CHEMBL4900	Homo sapiens	Inhibition	%	3.09
	8077124	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	9.02	CHEMBL4900	Homo sapiens	Inhibition	%	9.02
	8077476	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.17	CHEMBL4900	Homo sapiens	Inhibition	%	2.17
	8077627	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.77	CHEMBL4900	Homo sapiens	Inhibition	%	1.77
	8077994	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.84	CHEMBL4900	Homo sapiens	Inhibition	%	4.84
	8078133	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.32	CHEMBL4900	Homo sapiens	Inhibition	%	-2.32
	8078357	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.89	CHEMBL4900	Homo sapiens	Inhibition	%	2.89
	8078459	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.54	CHEMBL4900	Homo sapiens	Inhibition	%	1.54
	8078709	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	66.28	CHEMBL4900	Homo sapiens	Inhibition	%	66.28
	8079049	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.13	CHEMBL4900	Homo sapiens	Inhibition	%	3.13
	8079207	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.81	CHEMBL4900	Homo sapiens	Inhibition	%	0.81
	8079431	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.51	CHEMBL4900	Homo sapiens	Inhibition	%	1.51
	8079573	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.5	CHEMBL4900	Homo sapiens	Inhibition	%	3.5
	8079936	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	17.96	CHEMBL4900	Homo sapiens	Inhibition	%	17.96
	8080041	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	9.97	CHEMBL4900	Homo sapiens	Inhibition	%	9.97
	8080265	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.62	CHEMBL4900	Homo sapiens	Inhibition	%	0.62
	8080293	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.41	CHEMBL4900	Homo sapiens	Inhibition	%	4.41
	8080517	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	62.07	CHEMBL4900	Homo sapiens	Inhibition	%	62.07
	8080632	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.24	CHEMBL4900	Homo sapiens	Inhibition	%	0.24
	8081020	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.79	CHEMBL4900	Homo sapiens	Inhibition	%	-0.79
	8081155	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.32	CHEMBL4900	Homo sapiens	Inhibition	%	4.32
	8081523	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	75.72	CHEMBL4900	Homo sapiens	Inhibition	%	75.72
	8081850	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.16	CHEMBL4900	Homo sapiens	Inhibition	%	3.16
	8082102	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.07	CHEMBL4900	Homo sapiens	Inhibition	%	-1.07
	8082215	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.88	CHEMBL4900	Homo sapiens	Inhibition	%	2.88
	8082439	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.25	CHEMBL4900	Homo sapiens	Inhibition	%	3.25
	8082612	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	29.07	CHEMBL4900	Homo sapiens	Inhibition	%	29.07
	8082735	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.36	CHEMBL4900	Homo sapiens	Inhibition	%	2.36
	8082959	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.79	CHEMBL4900	Homo sapiens	Inhibition	%	2.79
	8083115	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	7.13	CHEMBL4900	Homo sapiens	Inhibition	%	7.13
	8083438	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.1	CHEMBL4900	Homo sapiens	Inhibition	%	2.1
	8083692	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.59	CHEMBL4900	Homo sapiens	Inhibition	%	4.59
	8084026	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	16.4	CHEMBL4900	Homo sapiens	Inhibition	%	16.4
	8084211	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	9.02	CHEMBL4900	Homo sapiens	Inhibition	%	9.02
	8084553	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.3	CHEMBL4900	Homo sapiens	Inhibition	%	3.3
	8084714	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	22.34	CHEMBL4900	Homo sapiens	Inhibition	%	22.34
	8085036	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.59	CHEMBL4900	Homo sapiens	Inhibition	%	3.59
	8085292	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.31	CHEMBL4900	Homo sapiens	Inhibition	%	-3.31
	8085624	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.44	CHEMBL4900	Homo sapiens	Inhibition	%	7.44
	8085813	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	55.71	CHEMBL4900	Homo sapiens	Inhibition	%	55.71
	8086152	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.01	CHEMBL4900	Homo sapiens	Inhibition	%	4.01
	8086314	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.9	CHEMBL4900	Homo sapiens	Inhibition	%	1.9
	8086538	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.6	CHEMBL4900	Homo sapiens	Inhibition	%	4.6
	8086637	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.34	CHEMBL4900	Homo sapiens	Inhibition	%	1.34
	8087072	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.77	CHEMBL4900	Homo sapiens	Inhibition	%	3.77
	8087230	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.86	CHEMBL4900	Homo sapiens	Inhibition	%	1.86
	8087568	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.84	CHEMBL4900	Homo sapiens	Inhibition	%	3.84
	8087706	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.28	CHEMBL4900	Homo sapiens	Inhibition	%	4.28
	8087930	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.14	CHEMBL4900	Homo sapiens	Inhibition	%	-1.14
	8088072	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.19	CHEMBL4900	Homo sapiens	Inhibition	%	4.19
	8088444	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.14	CHEMBL4900	Homo sapiens	Inhibition	%	1.14
	8088572	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.18	CHEMBL4900	Homo sapiens	Inhibition	%	4.18
	8088889	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.37	CHEMBL4900	Homo sapiens	Inhibition	%	4.37
	8089241	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	8.74	CHEMBL4900	Homo sapiens	Inhibition	%	8.74
	8089389	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.05	CHEMBL4900	Homo sapiens	Inhibition	%	-0.05
	8089733	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.21	CHEMBL4900	Homo sapiens	Inhibition	%	1.21
	8089913	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.04	CHEMBL4900	Homo sapiens	Inhibition	%	3.04
	8090302	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	8.82	CHEMBL4900	Homo sapiens	Inhibition	%	8.82
	8090469	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.7	CHEMBL4900	Homo sapiens	Inhibition	%	2.7
	8090832	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.68	CHEMBL4900	Homo sapiens	Inhibition	%	3.68
	8091037	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.78	CHEMBL4900	Homo sapiens	Inhibition	%	2.78
	8091398	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	25.13	CHEMBL4900	Homo sapiens	Inhibition	%	25.13
	8091553	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.39	CHEMBL4900	Homo sapiens	Inhibition	%	0.39
	8091777	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.96	CHEMBL4900	Homo sapiens	Inhibition	%	2.96
	8091893	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.18	CHEMBL4900	Homo sapiens	Inhibition	%	2.18
	8092254	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.29	CHEMBL4900	Homo sapiens	Inhibition	%	4.29
	8092405	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.1	CHEMBL4900	Homo sapiens	Inhibition	%	4.1
	8092777	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.32	CHEMBL4900	Homo sapiens	Inhibition	%	-1.32
	8092906	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.84	CHEMBL4900	Homo sapiens	Inhibition	%	2.84
	8093130	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.02	CHEMBL4900	Homo sapiens	Inhibition	%	-0.02
	8093218	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.01	CHEMBL4900	Homo sapiens	Inhibition	%	2.01
	8093582	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.26	CHEMBL4900	Homo sapiens	Inhibition	%	-0.26
	8093721	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	12.24	CHEMBL4900	Homo sapiens	Inhibition	%	12.24
	8093945	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.05	CHEMBL4900	Homo sapiens	Inhibition	%	-3.05
	8094065	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.98	CHEMBL4900	Homo sapiens	Inhibition	%	1.98
	8094245	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.97	CHEMBL4900	Homo sapiens	Inhibition	%	0.97
	8094469	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.37	CHEMBL4900	Homo sapiens	Inhibition	%	2.37
	8094644	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	59.89	CHEMBL4900	Homo sapiens	Inhibition	%	59.89
	8094800	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.01	CHEMBL4900	Homo sapiens	Inhibition	%	2.01
	8095024	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.53	CHEMBL4900	Homo sapiens	Inhibition	%	2.53
	8095164	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.78	CHEMBL4900	Homo sapiens	Inhibition	%	3.78
	8095367	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.54	CHEMBL4900	Homo sapiens	Inhibition	%	2.54
	8095591	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.96	CHEMBL4900	Homo sapiens	Inhibition	%	5.96
	8095732	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	68.48	CHEMBL4900	Homo sapiens	Inhibition	%	68.48
	8096104	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	Inhibition	%	3.0
	8096221	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.73	CHEMBL4900	Homo sapiens	Inhibition	%	4.73
	8096584	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.16	CHEMBL4900	Homo sapiens	Inhibition	%	1.16
	8096740	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.68	CHEMBL4900	Homo sapiens	Inhibition	%	4.68
	8096964	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.91	CHEMBL4900	Homo sapiens	Inhibition	%	4.91
	8097111	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.2	CHEMBL4900	Homo sapiens	Inhibition	%	-1.2
	8097418	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	16.86	CHEMBL4900	Homo sapiens	Inhibition	%	16.86
	8097642	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.26	CHEMBL4900	Homo sapiens	Inhibition	%	1.26
	8097792	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	8.54	CHEMBL4900	Homo sapiens	Inhibition	%	8.54
	8098149	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.55	CHEMBL4900	Homo sapiens	Inhibition	%	-1.55
	8098269	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.64	CHEMBL4900	Homo sapiens	Inhibition	%	1.64
	8098493	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.96	CHEMBL4900	Homo sapiens	Inhibition	%	0.96
	8098673	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.12	CHEMBL4900	Homo sapiens	Inhibition	%	3.12
	8098858	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	83.94	CHEMBL4900	Homo sapiens	Inhibition	%	83.94
	8099226	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.1	CHEMBL4900	Homo sapiens	Inhibition	%	2.1
	8099368	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.5	CHEMBL4900	Homo sapiens	Inhibition	%	2.5
	8099786	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	44.21	CHEMBL4900	Homo sapiens	Inhibition	%	44.21
	8099933	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.6	CHEMBL4900	Homo sapiens	Inhibition	%	6.6
	8100303	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.15	CHEMBL4900	Homo sapiens	Inhibition	%	-0.15
	8100419	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.6	CHEMBL4900	Homo sapiens	Inhibition	%	4.6
	8100643	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.63	CHEMBL4900	Homo sapiens	Inhibition	%	4.63
	8100783	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.77	CHEMBL4900	Homo sapiens	Inhibition	%	1.77
	8101167	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.71	CHEMBL4900	Homo sapiens	Inhibition	%	5.71
	8101309	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.6	CHEMBL4900	Homo sapiens	Inhibition	%	-0.6
	8101718	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.98	CHEMBL4900	Homo sapiens	Inhibition	%	-2.98
	8101971	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	5.96	CHEMBL4900	Homo sapiens	Inhibition	%	5.96
	8102126	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.94	CHEMBL4900	Homo sapiens	Inhibition	%	-1.94
	8102481	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.75	CHEMBL4900	Homo sapiens	Inhibition	%	0.75
	8102825	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	18.83	CHEMBL4900	Homo sapiens	Inhibition	%	18.83
	8103003	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.58	CHEMBL4900	Homo sapiens	Inhibition	%	2.58
	8103199	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.65	CHEMBL4900	Homo sapiens	Inhibition	%	5.65
	8103423	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	25.58	CHEMBL4900	Homo sapiens	Inhibition	%	25.58
	8103561	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.71	CHEMBL4900	Homo sapiens	Inhibition	%	0.71
	8103711	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.55	CHEMBL4900	Homo sapiens	Inhibition	%	2.55
	8103935	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	Inhibition	%	4.0
	8104120	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.6	CHEMBL4900	Homo sapiens	Inhibition	%	1.6
	8104268	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	8.29	CHEMBL4900	Homo sapiens	Inhibition	%	8.29
	8104492	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.73	CHEMBL4900	Homo sapiens	Inhibition	%	7.73
	8104638	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	9.15	CHEMBL4900	Homo sapiens	Inhibition	%	9.15
	8104976	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.05	CHEMBL4900	Homo sapiens	Inhibition	%	5.05
	8105116	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.44	CHEMBL4900	Homo sapiens	Inhibition	%	1.44
	8105340	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.15	CHEMBL4900	Homo sapiens	Inhibition	%	1.15
	8105506	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.7	CHEMBL4900	Homo sapiens	Inhibition	%	0.7
	8105644	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.05	CHEMBL4900	Homo sapiens	Inhibition	%	-0.05
	8105868	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.39	CHEMBL4900	Homo sapiens	Inhibition	%	3.39
	8105924	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.88	CHEMBL4900	Homo sapiens	Inhibition	%	1.88
	8106148	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.79	CHEMBL4900	Homo sapiens	Inhibition	%	3.79
	8106313	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.36	CHEMBL4900	Homo sapiens	Inhibition	%	-1.36
	8106469	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	Inhibition	%	5.0
	8106693	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.14	CHEMBL4900	Homo sapiens	Inhibition	%	-2.14
	8106822	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.51	CHEMBL4900	Homo sapiens	Inhibition	%	1.51
	8107167	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.85	CHEMBL4900	Homo sapiens	Inhibition	%	2.85
	8107339	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.96	CHEMBL4900	Homo sapiens	Inhibition	%	1.96
	8107764	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.21	CHEMBL4900	Homo sapiens	Inhibition	%	3.21
	8107899	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.2	CHEMBL4900	Homo sapiens	Inhibition	%	0.2
	8108281	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.27	CHEMBL4900	Homo sapiens	Inhibition	%	4.27
	8108456	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.04	CHEMBL4900	Homo sapiens	Inhibition	%	2.04
	8108827	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	12.13	CHEMBL4900	Homo sapiens	Inhibition	%	12.13
	8108969	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.72	CHEMBL4900	Homo sapiens	Inhibition	%	1.72
	8109307	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.84	CHEMBL4900	Homo sapiens	Inhibition	%	5.84
	8109661	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.3	CHEMBL4900	Homo sapiens	Inhibition	%	-1.3
	8109832	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.06	CHEMBL4900	Homo sapiens	Inhibition	%	1.06
	8110188	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.86	CHEMBL4900	Homo sapiens	Inhibition	%	1.86
	8110467	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.98	CHEMBL4900	Homo sapiens	Inhibition	%	1.98
	8110633	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.34	CHEMBL4900	Homo sapiens	Inhibition	%	0.34
	8111015	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.48	CHEMBL4900	Homo sapiens	Inhibition	%	0.48
	8111138	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.52	CHEMBL4900	Homo sapiens	Inhibition	%	0.52
	8111362	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.88	CHEMBL4900	Homo sapiens	Inhibition	%	1.88
	8111489	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	4.02	CHEMBL4900	Homo sapiens	Inhibition	%	4.02
	8111655	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.17	CHEMBL4900	Homo sapiens	Inhibition	%	2.17
	8111879	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.9	CHEMBL4900	Homo sapiens	Inhibition	%	0.9
	8112084	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.61	CHEMBL4900	Homo sapiens	Inhibition	%	3.61
	8112221	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.82	CHEMBL4900	Homo sapiens	Inhibition	%	0.82
	8112445	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.17	CHEMBL4900	Homo sapiens	Inhibition	%	-1.17
	8112613	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	8.43	CHEMBL4900	Homo sapiens	Inhibition	%	8.43
	8112785	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.46	CHEMBL4900	Homo sapiens	Inhibition	%	1.46
	8113009	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.7	CHEMBL4900	Homo sapiens	Inhibition	%	1.7
	8113161	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.9	CHEMBL4900	Homo sapiens	Inhibition	%	4.9
	8113297	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.14	CHEMBL4900	Homo sapiens	Inhibition	%	2.14
	8113521	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.95	CHEMBL4900	Homo sapiens	Inhibition	%	-0.95
	8113645	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	14.2	CHEMBL4900	Homo sapiens	Inhibition	%	14.2
	8113985	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.47	CHEMBL4900	Homo sapiens	Inhibition	%	0.47
	8114161	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.3	CHEMBL4900	Homo sapiens	Inhibition	%	5.3
	8114517	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.13	CHEMBL4900	Homo sapiens	Inhibition	%	4.13
	8114793	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.9	CHEMBL4900	Homo sapiens	Inhibition	%	2.9
	8114959	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.19	CHEMBL4900	Homo sapiens	Inhibition	%	1.19
	8115183	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.3	CHEMBL4900	Homo sapiens	Inhibition	%	1.3
	8115348	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.45	CHEMBL4900	Homo sapiens	Inhibition	%	-1.45
	8115692	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.4	CHEMBL4900	Homo sapiens	Inhibition	%	0.4
	8115825	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	12.62	CHEMBL4900	Homo sapiens	Inhibition	%	12.62
	8116208	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	11.83	CHEMBL4900	Homo sapiens	Inhibition	%	11.83
	8116411	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.98	CHEMBL4900	Homo sapiens	Inhibition	%	3.98
	8116769	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.15	CHEMBL4900	Homo sapiens	Inhibition	%	-0.15
	8116941	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	43.82	CHEMBL4900	Homo sapiens	Inhibition	%	43.82
	8117336	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.05	CHEMBL4900	Homo sapiens	Inhibition	%	0.05
	8117494	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.32	CHEMBL4900	Homo sapiens	Inhibition	%	7.32
	8117848	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.61	CHEMBL4900	Homo sapiens	Inhibition	%	-0.61
	8117986	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.25	CHEMBL4900	Homo sapiens	Inhibition	%	1.25
	8118210	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.98	CHEMBL4900	Homo sapiens	Inhibition	%	3.98
	8118326	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.83	CHEMBL4900	Homo sapiens	Inhibition	%	3.83
	8118498	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.34	CHEMBL4900	Homo sapiens	Inhibition	%	4.34
	8118722	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.03	CHEMBL4900	Homo sapiens	Inhibition	%	4.03
	8118858	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.52	CHEMBL4900	Homo sapiens	Inhibition	%	2.52
	8119129	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.43	CHEMBL4900	Homo sapiens	Inhibition	%	3.43
	8119512	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.16	CHEMBL4900	Homo sapiens	Inhibition	%	1.16
	8119679	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.67	CHEMBL4900	Homo sapiens	Inhibition	%	-0.67
	8120022	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.87	CHEMBL4900	Homo sapiens	Inhibition	%	2.87
	8120161	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.13	CHEMBL4900	Homo sapiens	Inhibition	%	2.13
	8120385	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.37	CHEMBL4900	Homo sapiens	Inhibition	%	2.37
	8120545	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.01	CHEMBL4900	Homo sapiens	Inhibition	%	1.01
	8120746	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	11.14	CHEMBL4900	Homo sapiens	Inhibition	%	11.14
	8121098	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.41	CHEMBL4900	Homo sapiens	Inhibition	%	-0.41
	8121270	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.17	CHEMBL4900	Homo sapiens	Inhibition	%	3.17
	8121494	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.56	CHEMBL4900	Homo sapiens	Inhibition	%	1.56
	8121661	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.82	CHEMBL4900	Homo sapiens	Inhibition	%	0.82
	8121824	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.73	CHEMBL4900	Homo sapiens	Inhibition	%	7.73
	8122169	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.28	CHEMBL4900	Homo sapiens	Inhibition	%	-0.28
	8122531	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	16.27	CHEMBL4900	Homo sapiens	Inhibition	%	16.27
	8122651	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.99	CHEMBL4900	Homo sapiens	Inhibition	%	1.99
	8123042	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.29	CHEMBL4900	Homo sapiens	Inhibition	%	5.29
	8123184	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.16	CHEMBL4900	Homo sapiens	Inhibition	%	1.16
	8123408	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-1.87	CHEMBL4900	Homo sapiens	Inhibition	%	-1.87
	8123462	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	31.87	CHEMBL4900	Homo sapiens	Inhibition	%	31.87
	8123836	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.86	CHEMBL4900	Homo sapiens	Inhibition	%	2.86
	8124003	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-4.34	CHEMBL4900	Homo sapiens	Inhibition	%	-4.34
	8124227	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-5.5	CHEMBL4900	Homo sapiens	Inhibition	%	-5.5
	8124346	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.78	CHEMBL4900	Homo sapiens	Inhibition	%	2.78
	8124709	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.15	CHEMBL4900	Homo sapiens	Inhibition	%	3.15
	8124874	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.12	CHEMBL4900	Homo sapiens	Inhibition	%	1.12
	8125075	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.63	CHEMBL4900	Homo sapiens	Inhibition	%	4.63
	8125299	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	13.72	CHEMBL4900	Homo sapiens	Inhibition	%	13.72
	8125429	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.06	CHEMBL4900	Homo sapiens	Inhibition	%	-1.06
	8125821	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.32	CHEMBL4900	Homo sapiens	Inhibition	%	3.32
	8125985	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.26	CHEMBL4900	Homo sapiens	Inhibition	%	0.26
	8126149	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.86	CHEMBL4900	Homo sapiens	Inhibition	%	6.86
	8126373	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	28.14	CHEMBL4900	Homo sapiens	Inhibition	%	28.14
	8126488	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.14	CHEMBL4900	Homo sapiens	Inhibition	%	0.14
	8126848	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	58.25	CHEMBL4900	Homo sapiens	Inhibition	%	58.25
	8126970	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.63	CHEMBL4900	Homo sapiens	Inhibition	%	4.63
	8127194	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.64	CHEMBL4900	Homo sapiens	Inhibition	%	5.64
	8127361	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.92	CHEMBL4900	Homo sapiens	Inhibition	%	3.92
	8127727	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.02	CHEMBL4900	Homo sapiens	Inhibition	%	5.02
	8127791	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.26	CHEMBL4900	Homo sapiens	Inhibition	%	1.26
	8128015	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	Inhibition	%	3.0
	8128167	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-2.38	CHEMBL4900	Homo sapiens	Inhibition	%	-2.38
	8128558	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	Inhibition	%	-1.0
	8128677	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	37.38	CHEMBL4900	Homo sapiens	Inhibition	%	37.38
	8129038	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.21	CHEMBL4900	Homo sapiens	Inhibition	%	2.21
	8129209	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.89	CHEMBL4900	Homo sapiens	Inhibition	%	0.89
	8129622	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.12	CHEMBL4900	Homo sapiens	Inhibition	%	2.12
	8129761	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.68	CHEMBL4900	Homo sapiens	Inhibition	%	0.68
	8130146	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.13	CHEMBL4900	Homo sapiens	Inhibition	%	2.13
	8130318	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.06	CHEMBL4900	Homo sapiens	Inhibition	%	0.06
	8130702	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	64.4	CHEMBL4900	Homo sapiens	Inhibition	%	64.4
	8130818	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.72	CHEMBL4900	Homo sapiens	Inhibition	%	3.72
	8131042	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.39	CHEMBL4900	Homo sapiens	Inhibition	%	2.39
	8131181	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.22	CHEMBL4900	Homo sapiens	Inhibition	%	6.22
	8131525	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.17	CHEMBL4900	Homo sapiens	Inhibition	%	-0.17
	8131692	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.8	CHEMBL4900	Homo sapiens	Inhibition	%	3.8
	8132057	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.09	CHEMBL4900	Homo sapiens	Inhibition	%	4.09
	8132343	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.04	CHEMBL4900	Homo sapiens	Inhibition	%	-2.04
	8132490	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.05	CHEMBL4900	Homo sapiens	Inhibition	%	2.05
	8132714	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.41	CHEMBL4900	Homo sapiens	Inhibition	%	1.41
	8132882	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.08	CHEMBL4900	Homo sapiens	Inhibition	%	-1.08
	8133003	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.12	CHEMBL4900	Homo sapiens	Inhibition	%	1.12
	8133227	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.34	CHEMBL4900	Homo sapiens	Inhibition	%	5.34
	8133365	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.45	CHEMBL4900	Homo sapiens	Inhibition	%	2.45
	8133537	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.9	CHEMBL4900	Homo sapiens	Inhibition	%	1.9
	8133761	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.84	CHEMBL4900	Homo sapiens	Inhibition	%	0.84
	8133941	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.43	CHEMBL4900	Homo sapiens	Inhibition	%	3.43
	8134089	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.34	CHEMBL4900	Homo sapiens	Inhibition	%	-0.34
	8134313	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.42	CHEMBL4900	Homo sapiens	Inhibition	%	-0.42
	8134473	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.39	CHEMBL4900	Homo sapiens	Inhibition	%	2.39
	8134657	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.04	CHEMBL4900	Homo sapiens	Inhibition	%	-0.04
	8134881	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.63	CHEMBL4900	Homo sapiens	Inhibition	%	2.63
	8135041	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.87	CHEMBL4900	Homo sapiens	Inhibition	%	6.87
	8135380	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.28	CHEMBL4900	Homo sapiens	Inhibition	%	3.28
	8135521	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	10.84	CHEMBL4900	Homo sapiens	Inhibition	%	10.84
	8135866	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.14	CHEMBL4900	Homo sapiens	Inhibition	%	-2.14
	8136034	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.74	CHEMBL4900	Homo sapiens	Inhibition	%	2.74
	8136258	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.36	CHEMBL4900	Homo sapiens	Inhibition	%	1.36
	8136402	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.35	CHEMBL4900	Homo sapiens	Inhibition	%	5.35
	8136692	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.62	CHEMBL4900	Homo sapiens	Inhibition	%	-0.62
	8137051	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.98	CHEMBL4900	Homo sapiens	Inhibition	%	5.98
	8137214	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-2.37	CHEMBL4900	Homo sapiens	Inhibition	%	-2.37
	8137558	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.56	CHEMBL4900	Homo sapiens	Inhibition	%	-2.56
	8137706	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.99	CHEMBL4900	Homo sapiens	Inhibition	%	2.99
	8138096	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.58	CHEMBL4900	Homo sapiens	Inhibition	%	1.58
	8138275	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.93	CHEMBL4900	Homo sapiens	Inhibition	%	1.93
	8138647	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.97	CHEMBL4900	Homo sapiens	Inhibition	%	-1.97
	8138805	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.55	CHEMBL4900	Homo sapiens	Inhibition	%	3.55
	8139214	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.97	CHEMBL4900	Homo sapiens	Inhibition	%	2.97
	8139373	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	12.23	CHEMBL4900	Homo sapiens	Inhibition	%	12.23
	8139711	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.47	CHEMBL4900	Homo sapiens	Inhibition	%	2.47
	8139852	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.6	CHEMBL4900	Homo sapiens	Inhibition	%	4.6
	8140076	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.63	CHEMBL4900	Homo sapiens	Inhibition	%	6.63
	8140199	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.51	CHEMBL4900	Homo sapiens	Inhibition	%	4.51
	8140582	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.4	CHEMBL4900	Homo sapiens	Inhibition	%	2.4
	8140725	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.53	CHEMBL4900	Homo sapiens	Inhibition	%	9.53
	8141027	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.71	CHEMBL4900	Homo sapiens	Inhibition	%	1.71
	8141381	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.13	CHEMBL4900	Homo sapiens	Inhibition	%	-0.13
	8141541	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.21	CHEMBL4900	Homo sapiens	Inhibition	%	1.21
	8141884	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.22	CHEMBL4900	Homo sapiens	Inhibition	%	-2.22
	8142045	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.69	CHEMBL4900	Homo sapiens	Inhibition	%	2.69
	8142269	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	9.73	CHEMBL4900	Homo sapiens	Inhibition	%	9.73
	8142437	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.29	CHEMBL4900	Homo sapiens	Inhibition	%	2.29
	8142613	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.2	CHEMBL4900	Homo sapiens	Inhibition	%	0.2
	8142837	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.95	CHEMBL4900	Homo sapiens	Inhibition	%	3.95
	8142986	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.88	CHEMBL4900	Homo sapiens	Inhibition	%	-0.88
	8143141	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.76	CHEMBL4900	Homo sapiens	Inhibition	%	3.76
	8143365	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.21	CHEMBL4900	Homo sapiens	Inhibition	%	2.21
	8143552	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.24	CHEMBL4900	Homo sapiens	Inhibition	%	1.24
	8143711	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	12.76	CHEMBL4900	Homo sapiens	Inhibition	%	12.76
	8143935	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	56.82	CHEMBL4900	Homo sapiens	Inhibition	%	56.82
	8144049	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.64	CHEMBL4900	Homo sapiens	Inhibition	%	0.64
	8144412	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.64	CHEMBL4900	Homo sapiens	Inhibition	%	3.64
	8144542	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.6	CHEMBL4900	Homo sapiens	Inhibition	%	3.6
	8144766	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.04	CHEMBL4900	Homo sapiens	Inhibition	%	4.04
	8144919	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.98	CHEMBL4900	Homo sapiens	Inhibition	%	1.98
	8145056	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.52	CHEMBL4900	Homo sapiens	Inhibition	%	5.52
	8145280	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.53	CHEMBL4900	Homo sapiens	Inhibition	%	4.53
	8145369	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.6	CHEMBL4900	Homo sapiens	Inhibition	%	3.6
	8145717	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.79	CHEMBL4900	Homo sapiens	Inhibition	%	1.79
	8145878	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.57	CHEMBL4900	Homo sapiens	Inhibition	%	0.57
	8146102	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.0	CHEMBL4900	Homo sapiens	Inhibition	%	2.0
	8146222	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.22	CHEMBL4900	Homo sapiens	Inhibition	%	-0.22
	8146606	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	12.23	CHEMBL4900	Homo sapiens	Inhibition	%	12.23
	8146773	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	22.05	CHEMBL4900	Homo sapiens	Inhibition	%	22.05
	8147166	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.02	CHEMBL4900	Homo sapiens	Inhibition	%	3.02
	8147308	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.86	CHEMBL4900	Homo sapiens	Inhibition	%	1.86
	8147685	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.6	CHEMBL4900	Homo sapiens	Inhibition	%	1.6
	8147872	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.47	CHEMBL4900	Homo sapiens	Inhibition	%	4.47
	8148254	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.47	CHEMBL4900	Homo sapiens	Inhibition	%	4.47
	8148368	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.34	CHEMBL4900	Homo sapiens	Inhibition	%	-2.34
	8148592	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.18	CHEMBL4900	Homo sapiens	Inhibition	%	4.18
	8148731	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.82	CHEMBL4900	Homo sapiens	Inhibition	%	8.82
	8149093	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.14	CHEMBL4900	Homo sapiens	Inhibition	%	3.14
	8149252	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.89	CHEMBL4900	Homo sapiens	Inhibition	%	-2.89
	8149610	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.41	CHEMBL4900	Homo sapiens	Inhibition	%	5.41
	8149708	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	Inhibition	%	3.0
	8149932	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.22	CHEMBL4900	Homo sapiens	Inhibition	%	4.22
	8150057	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.46	CHEMBL4900	Homo sapiens	Inhibition	%	-3.46
	8150441	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.57	CHEMBL4900	Homo sapiens	Inhibition	%	-0.57
	8150561	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.52	CHEMBL4900	Homo sapiens	Inhibition	%	0.52
	8150785	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.52	CHEMBL4900	Homo sapiens	Inhibition	%	0.52
	8150950	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	39.67	CHEMBL4900	Homo sapiens	Inhibition	%	39.67
	8151113	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.91	CHEMBL4900	Homo sapiens	Inhibition	%	-2.91
	8151337	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.22	CHEMBL4900	Homo sapiens	Inhibition	%	0.22
	8151514	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.36	CHEMBL4900	Homo sapiens	Inhibition	%	2.36
	8151652	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.49	CHEMBL4900	Homo sapiens	Inhibition	%	1.49
	8151876	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.62	CHEMBL4900	Homo sapiens	Inhibition	%	3.62
	8152030	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.1	CHEMBL4900	Homo sapiens	Inhibition	%	3.1
	8152218	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.79	CHEMBL4900	Homo sapiens	Inhibition	%	3.79
	8152442	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.54	CHEMBL4900	Homo sapiens	Inhibition	%	1.54
	8152600	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	8.41	CHEMBL4900	Homo sapiens	Inhibition	%	8.41
	8152938	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.25	CHEMBL4900	Homo sapiens	Inhibition	%	3.25
	8153077	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.14	CHEMBL4900	Homo sapiens	Inhibition	%	2.14
	8153438	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.57	CHEMBL4900	Homo sapiens	Inhibition	%	5.57
	8153595	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.76	CHEMBL4900	Homo sapiens	Inhibition	%	-4.76
	8153819	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.22	CHEMBL4900	Homo sapiens	Inhibition	%	0.22
	8153952	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.38	CHEMBL4900	Homo sapiens	Inhibition	%	5.38
	8154273	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.41	CHEMBL4900	Homo sapiens	Inhibition	%	2.41
	8154399	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.48	CHEMBL4900	Homo sapiens	Inhibition	%	-1.48
	8154623	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.33	CHEMBL4900	Homo sapiens	Inhibition	%	-0.33
	8154782	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.02	CHEMBL4900	Homo sapiens	Inhibition	%	2.02
	8155126	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.33	CHEMBL4900	Homo sapiens	Inhibition	%	2.33
	8155302	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.62	CHEMBL4900	Homo sapiens	Inhibition	%	1.62
	8155687	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.84	CHEMBL4900	Homo sapiens	Inhibition	%	4.84
	8155865	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.14	CHEMBL4900	Homo sapiens	Inhibition	%	3.14
	8156227	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.84	CHEMBL4900	Homo sapiens	Inhibition	%	1.84
	8156439	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.1	CHEMBL4900	Homo sapiens	Inhibition	%	4.1
	8156589	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	Inhibition	%	1.0
	8156813	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.0	CHEMBL4900	Homo sapiens	Inhibition	%	2.0
	8156956	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.55	CHEMBL4900	Homo sapiens	Inhibition	%	5.55
	8157300	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.33	CHEMBL4900	Homo sapiens	Inhibition	%	4.33
	8157441	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.81	CHEMBL4900	Homo sapiens	Inhibition	%	1.81
	8157665	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.32	CHEMBL4900	Homo sapiens	Inhibition	%	4.32
	8157795	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.77	CHEMBL4900	Homo sapiens	Inhibition	%	7.77
	8157956	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.2	CHEMBL4900	Homo sapiens	Inhibition	%	4.2
	8158180	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.52	CHEMBL4900	Homo sapiens	Inhibition	%	-2.52
	8158430	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.65	CHEMBL4900	Homo sapiens	Inhibition	%	6.65
	8158588	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.48	CHEMBL4900	Homo sapiens	Inhibition	%	9.48
	8158981	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.95	CHEMBL4900	Homo sapiens	Inhibition	%	4.95
	8159116	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.18	CHEMBL4900	Homo sapiens	Inhibition	%	6.18
	8159460	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.29	CHEMBL4900	Homo sapiens	Inhibition	%	-0.29
	8159815	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	25.89	CHEMBL4900	Homo sapiens	Inhibition	%	25.89
	8159956	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.47	CHEMBL4900	Homo sapiens	Inhibition	%	4.47
	8160317	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.36	CHEMBL4900	Homo sapiens	Inhibition	%	6.36
	8160467	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.03	CHEMBL4900	Homo sapiens	Inhibition	%	0.03
	8160761	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.17	CHEMBL4900	Homo sapiens	Inhibition	%	6.17
	8161135	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.04	CHEMBL4900	Homo sapiens	Inhibition	%	1.04
	8161278	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.55	CHEMBL4900	Homo sapiens	Inhibition	%	5.55
	8161627	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.91	CHEMBL4900	Homo sapiens	Inhibition	%	1.91
	8161989	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.47	CHEMBL4900	Homo sapiens	Inhibition	%	2.47
	8162119	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.26	CHEMBL4900	Homo sapiens	Inhibition	%	3.26
	8162503	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.73	CHEMBL4900	Homo sapiens	Inhibition	%	-0.73
	8162756	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.24	CHEMBL4900	Homo sapiens	Inhibition	%	8.24
	8162904	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	21.31	CHEMBL4900	Homo sapiens	Inhibition	%	21.31
	8163128	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	79.05	CHEMBL4900	Homo sapiens	Inhibition	%	79.05
	8163297	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.17	CHEMBL4900	Homo sapiens	Inhibition	%	2.17
	8163431	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.01	CHEMBL4900	Homo sapiens	Inhibition	%	6.01
	8163655	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.68	CHEMBL4900	Homo sapiens	Inhibition	%	5.68
	8163778	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.4	CHEMBL4900	Homo sapiens	Inhibition	%	0.4
	8164136	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	81.13	CHEMBL4900	Homo sapiens	Inhibition	%	81.13
	8164276	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.47	CHEMBL4900	Homo sapiens	Inhibition	%	1.47
	8164500	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.58	CHEMBL4900	Homo sapiens	Inhibition	%	3.58
	8164655	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.36	CHEMBL4900	Homo sapiens	Inhibition	%	7.36
	8164799	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	23.29	CHEMBL4900	Homo sapiens	Inhibition	%	23.29
	8165023	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.14	CHEMBL4900	Homo sapiens	Inhibition	%	3.14
	8165093	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.16	CHEMBL4900	Homo sapiens	Inhibition	%	7.16
	8165317	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	41.65	CHEMBL4900	Homo sapiens	Inhibition	%	41.65
	8165458	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.37	CHEMBL4900	Homo sapiens	Inhibition	%	2.37
	8165601	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	38.2	CHEMBL4900	Homo sapiens	Inhibition	%	38.2
	8165825	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.61	CHEMBL4900	Homo sapiens	Inhibition	%	1.61
	8165951	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.71	CHEMBL4900	Homo sapiens	Inhibition	%	2.71
	8166313	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.29	CHEMBL4900	Homo sapiens	Inhibition	%	3.29
	8166443	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.64	CHEMBL4900	Homo sapiens	Inhibition	%	3.64
	8166667	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.13	CHEMBL4900	Homo sapiens	Inhibition	%	7.13
	8166768	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.94	CHEMBL4900	Homo sapiens	Inhibition	%	2.94
	8167080	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.04	CHEMBL4900	Homo sapiens	Inhibition	%	3.04
	8167445	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	17.51	CHEMBL4900	Homo sapiens	Inhibition	%	17.51
	8167609	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.96	CHEMBL4900	Homo sapiens	Inhibition	%	2.96
	8167966	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.33	CHEMBL4900	Homo sapiens	Inhibition	%	5.33
	8168090	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.76	CHEMBL4900	Homo sapiens	Inhibition	%	3.76
	8168314	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	8.48	CHEMBL4900	Homo sapiens	Inhibition	%	8.48
	8168455	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.41	CHEMBL4900	Homo sapiens	Inhibition	%	7.41
	8168815	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.79	CHEMBL4900	Homo sapiens	Inhibition	%	-0.79
	8168979	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	46.76	CHEMBL4900	Homo sapiens	Inhibition	%	46.76
	8169345	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.01	CHEMBL4900	Homo sapiens	Inhibition	%	5.01
	8169649	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.45	CHEMBL4900	Homo sapiens	Inhibition	%	5.45
	8169783	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.74	CHEMBL4900	Homo sapiens	Inhibition	%	1.74
	8170152	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.29	CHEMBL4900	Homo sapiens	Inhibition	%	1.29
	8170277	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.72	CHEMBL4900	Homo sapiens	Inhibition	%	2.72
	8170501	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.1	CHEMBL4900	Homo sapiens	Inhibition	%	3.1
	8170641	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.27	CHEMBL4900	Homo sapiens	Inhibition	%	-0.27
	8171000	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.32	CHEMBL4900	Homo sapiens	Inhibition	%	1.32
	8171197	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.03	CHEMBL4900	Homo sapiens	Inhibition	%	1.03
	8171414	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.52	CHEMBL4900	Homo sapiens	Inhibition	%	4.52
	8171779	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	75.72	CHEMBL4900	Homo sapiens	Inhibition	%	75.72
	8171932	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.06	CHEMBL4900	Homo sapiens	Inhibition	%	-1.06
	8172156	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.18	CHEMBL4900	Homo sapiens	Inhibition	%	-1.18
	8172288	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.28	CHEMBL4900	Homo sapiens	Inhibition	%	5.28
	8172640	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	14.62	CHEMBL4900	Homo sapiens	Inhibition	%	14.62
	8172782	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	32.68	CHEMBL4900	Homo sapiens	Inhibition	%	32.68
	8173142	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.76	CHEMBL4900	Homo sapiens	Inhibition	%	-0.76
	8173307	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.75	CHEMBL4900	Homo sapiens	Inhibition	%	4.75
	8173531	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.06	CHEMBL4900	Homo sapiens	Inhibition	%	9.06
	8173672	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.88	CHEMBL4900	Homo sapiens	Inhibition	%	3.88
	8173983	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	32.94	CHEMBL4900	Homo sapiens	Inhibition	%	32.94
	8174115	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.87	CHEMBL4900	Homo sapiens	Inhibition	%	3.87
	8174339	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	Inhibition	%	4.0
	8174487	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.36	CHEMBL4900	Homo sapiens	Inhibition	%	2.36
	8174833	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.15	CHEMBL4900	Homo sapiens	Inhibition	%	2.15
	8174976	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.59	CHEMBL4900	Homo sapiens	Inhibition	%	3.59
	8175336	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	15.58	CHEMBL4900	Homo sapiens	Inhibition	%	15.58
	8175592	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.07	CHEMBL4900	Homo sapiens	Inhibition	%	6.07
	8175755	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.66	CHEMBL4900	Homo sapiens	Inhibition	%	3.66
	8175979	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.2	CHEMBL4900	Homo sapiens	Inhibition	%	4.2
	8176132	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.58	CHEMBL4900	Homo sapiens	Inhibition	%	8.58
	8176505	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.23	CHEMBL4900	Homo sapiens	Inhibition	%	1.23
	8176637	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	Inhibition	%	14.0
	8176991	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	64.34	CHEMBL4900	Homo sapiens	Inhibition	%	64.34
	8177133	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.35	CHEMBL4900	Homo sapiens	Inhibition	%	2.35
	8177357	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.1	CHEMBL4900	Homo sapiens	Inhibition	%	4.1
	8177495	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	8.15	CHEMBL4900	Homo sapiens	Inhibition	%	8.15
	8177883	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.22	CHEMBL4900	Homo sapiens	Inhibition	%	8.22
	8178023	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.38	CHEMBL4900	Homo sapiens	Inhibition	%	4.38
	8178335	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.3	CHEMBL4900	Homo sapiens	Inhibition	%	2.3
	8178686	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.35	CHEMBL4900	Homo sapiens	Inhibition	%	3.35
	8178835	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.14	CHEMBL4900	Homo sapiens	Inhibition	%	2.14
	8179182	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.71	CHEMBL4900	Homo sapiens	Inhibition	%	3.71
	8179326	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.54	CHEMBL4900	Homo sapiens	Inhibition	%	6.54
	8179550	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	18.53	CHEMBL4900	Homo sapiens	Inhibition	%	18.53
	8179687	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.95	CHEMBL4900	Homo sapiens	Inhibition	%	0.95
	8179944	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.78	CHEMBL4900	Homo sapiens	Inhibition	%	4.78
	8180322	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.92	CHEMBL4900	Homo sapiens	Inhibition	%	-0.92
	8180478	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	41.26	CHEMBL4900	Homo sapiens	Inhibition	%	41.26
	8180850	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.28	CHEMBL4900	Homo sapiens	Inhibition	%	5.28
	8180983	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.07	CHEMBL4900	Homo sapiens	Inhibition	%	7.07
	8181207	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	33.24	CHEMBL4900	Homo sapiens	Inhibition	%	33.24
	8181338	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.69	CHEMBL4900	Homo sapiens	Inhibition	%	0.69
	8181702	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.79	CHEMBL4900	Homo sapiens	Inhibition	%	4.79
	8181841	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	45.86	CHEMBL4900	Homo sapiens	Inhibition	%	45.86
	8182228	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	51.85	CHEMBL4900	Homo sapiens	Inhibition	%	51.85
	8182368	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.45	CHEMBL4900	Homo sapiens	Inhibition	%	3.45
	8182592	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.98	CHEMBL4900	Homo sapiens	Inhibition	%	3.98
	8182684	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.92	CHEMBL4900	Homo sapiens	Inhibition	%	1.92
	8183030	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.35	CHEMBL4900	Homo sapiens	Inhibition	%	3.35
	8183179	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.35	CHEMBL4900	Homo sapiens	Inhibition	%	2.35
	8183403	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.71	CHEMBL4900	Homo sapiens	Inhibition	%	3.71
	8183532	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.7	CHEMBL4900	Homo sapiens	Inhibition	%	0.7
	8183898	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.87	CHEMBL4900	Homo sapiens	Inhibition	%	3.87
	8184034	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.95	CHEMBL4900	Homo sapiens	Inhibition	%	1.95
	8184258	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.64	CHEMBL4900	Homo sapiens	Inhibition	%	-2.64
	8184300	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.42	CHEMBL4900	Homo sapiens	Inhibition	%	6.42
	8184524	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.13	CHEMBL4900	Homo sapiens	Inhibition	%	5.13
	8184671	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.9	CHEMBL4900	Homo sapiens	Inhibition	%	-2.9
	8184828	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	8.87	CHEMBL4900	Homo sapiens	Inhibition	%	8.87
	8185052	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	52.1	CHEMBL4900	Homo sapiens	Inhibition	%	52.1
	8185201	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.45	CHEMBL4900	Homo sapiens	Inhibition	%	0.45
	8185556	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.1	CHEMBL4900	Homo sapiens	Inhibition	%	4.1
	8185687	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	11.28	CHEMBL4900	Homo sapiens	Inhibition	%	11.28
	8186050	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.1	CHEMBL4900	Homo sapiens	Inhibition	%	5.1
	8186191	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.52	CHEMBL4900	Homo sapiens	Inhibition	%	3.52
	8186415	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.42	CHEMBL4900	Homo sapiens	Inhibition	%	5.42
	8186579	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.06	CHEMBL4900	Homo sapiens	Inhibition	%	5.06
	8186942	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.75	CHEMBL4900	Homo sapiens	Inhibition	%	3.75
	8187040	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.04	CHEMBL4900	Homo sapiens	Inhibition	%	2.04
	8187264	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.16	CHEMBL4900	Homo sapiens	Inhibition	%	2.16
	8187388	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.92	CHEMBL4900	Homo sapiens	Inhibition	%	3.92
	8187760	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.28	CHEMBL4900	Homo sapiens	Inhibition	%	3.28
	8187889	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.07	CHEMBL4900	Homo sapiens	Inhibition	%	3.07
	8188113	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.8	CHEMBL4900	Homo sapiens	Inhibition	%	0.8
	8188256	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.28	CHEMBL4900	Homo sapiens	Inhibition	%	5.28
	8188615	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.8	CHEMBL4900	Homo sapiens	Inhibition	%	-2.8
	8188889	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.23	CHEMBL4900	Homo sapiens	Inhibition	%	7.23
	8189037	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.45	CHEMBL4900	Homo sapiens	Inhibition	%	1.45
	8189417	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.88	CHEMBL4900	Homo sapiens	Inhibition	%	3.88
	8189566	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.16	CHEMBL4900	Homo sapiens	Inhibition	%	2.16
	8189922	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	26.66	CHEMBL4900	Homo sapiens	Inhibition	%	26.66
	8190054	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.74	CHEMBL4900	Homo sapiens	Inhibition	%	4.74
	8190278	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.48	CHEMBL4900	Homo sapiens	Inhibition	%	6.48
	8190418	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.01	CHEMBL4900	Homo sapiens	Inhibition	%	5.01
	8190779	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.75	CHEMBL4900	Homo sapiens	Inhibition	%	4.75
	8190943	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.9	CHEMBL4900	Homo sapiens	Inhibition	%	7.9
	8191305	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.51	CHEMBL4900	Homo sapiens	Inhibition	%	6.51
	8191625	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.6	CHEMBL4900	Homo sapiens	Inhibition	%	2.6
	8191747	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.35	CHEMBL4900	Homo sapiens	Inhibition	%	5.35
	8191971	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.49	CHEMBL4900	Homo sapiens	Inhibition	%	2.49
	8192120	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.18	CHEMBL4900	Homo sapiens	Inhibition	%	7.18
	8192473	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.08	CHEMBL4900	Homo sapiens	Inhibition	%	1.08
	8192617	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.71	CHEMBL4900	Homo sapiens	Inhibition	%	3.71
	8192977	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.66	CHEMBL4900	Homo sapiens	Inhibition	%	0.66
	8193249	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.51	CHEMBL4900	Homo sapiens	Inhibition	%	3.51
	8193394	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.41	CHEMBL4900	Homo sapiens	Inhibition	%	1.41
	8193618	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.54	CHEMBL4900	Homo sapiens	Inhibition	%	-0.54
	8193775	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.99	CHEMBL4900	Homo sapiens	Inhibition	%	10.99
	8193924	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.19	CHEMBL4900	Homo sapiens	Inhibition	%	-1.19
	8194148	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.31	CHEMBL4900	Homo sapiens	Inhibition	%	-0.31
	8194279	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.41	CHEMBL4900	Homo sapiens	Inhibition	%	5.41
	8194634	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.57	CHEMBL4900	Homo sapiens	Inhibition	%	4.57
	8194777	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.63	CHEMBL4900	Homo sapiens	Inhibition	%	5.63
	8195001	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.21	CHEMBL4900	Homo sapiens	Inhibition	%	5.21
	8195134	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	14.8	CHEMBL4900	Homo sapiens	Inhibition	%	14.8
	8195298	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.72	CHEMBL4900	Homo sapiens	Inhibition	%	2.72
	8195522	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.54	CHEMBL4900	Homo sapiens	Inhibition	%	5.54
	8195661	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.75	CHEMBL4900	Homo sapiens	Inhibition	%	4.75
	8195983	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.33	CHEMBL4900	Homo sapiens	Inhibition	%	2.33
	8196324	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.57	CHEMBL4900	Homo sapiens	Inhibition	%	4.57
	8196474	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	24.59	CHEMBL4900	Homo sapiens	Inhibition	%	24.59
	8196826	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.61	CHEMBL4900	Homo sapiens	Inhibition	%	-1.61
	8196967	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.79	CHEMBL4900	Homo sapiens	Inhibition	%	3.79
	8197191	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.47	CHEMBL4900	Homo sapiens	Inhibition	%	2.47
	8197328	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.81	CHEMBL4900	Homo sapiens	Inhibition	%	0.81
	8197603	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.06	CHEMBL4900	Homo sapiens	Inhibition	%	4.06
	8197967	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.64	CHEMBL4900	Homo sapiens	Inhibition	%	1.64
	8198124	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.09	CHEMBL4900	Homo sapiens	Inhibition	%	2.09
	8198486	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.43	CHEMBL4900	Homo sapiens	Inhibition	%	6.43
	8198616	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	10.51	CHEMBL4900	Homo sapiens	Inhibition	%	10.51
	8198840	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.88	CHEMBL4900	Homo sapiens	Inhibition	%	4.88
	8198971	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.56	CHEMBL4900	Homo sapiens	Inhibition	%	4.56
	8199343	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.15	CHEMBL4900	Homo sapiens	Inhibition	%	5.15
	8199477	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.16	CHEMBL4900	Homo sapiens	Inhibition	%	5.16
	8199864	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.79	CHEMBL4900	Homo sapiens	Inhibition	%	1.79
	8200002	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	9.51	CHEMBL4900	Homo sapiens	Inhibition	%	9.51
	8200226	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.27	CHEMBL4900	Homo sapiens	Inhibition	%	6.27
	8200330	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.23	CHEMBL4900	Homo sapiens	Inhibition	%	1.23
	8200669	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.81	CHEMBL4900	Homo sapiens	Inhibition	%	2.81
	8200819	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	87.0	CHEMBL4900	Homo sapiens	Inhibition	%	87.0
	8201043	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.38	CHEMBL4900	Homo sapiens	Inhibition	%	6.38
	8201173	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.96	CHEMBL4900	Homo sapiens	Inhibition	%	-0.96
	8201532	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.54	CHEMBL4900	Homo sapiens	Inhibition	%	4.54
	8201665	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.62	CHEMBL4900	Homo sapiens	Inhibition	%	-0.62
	8201944	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.63	CHEMBL4900	Homo sapiens	Inhibition	%	4.63
	8202308	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.06	CHEMBL4900	Homo sapiens	Inhibition	%	-2.06
	8202475	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.85	CHEMBL4900	Homo sapiens	Inhibition	%	3.85
	8202824	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	32.42	CHEMBL4900	Homo sapiens	Inhibition	%	32.42
	8203178	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.11	CHEMBL4900	Homo sapiens	Inhibition	%	6.11
	8203309	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.1	CHEMBL4900	Homo sapiens	Inhibition	%	1.1
	8203679	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.62	CHEMBL4900	Homo sapiens	Inhibition	%	3.62
	8203813	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.54	CHEMBL4900	Homo sapiens	Inhibition	%	6.54
	8204037	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	9.14	CHEMBL4900	Homo sapiens	Inhibition	%	9.14
	8204203	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.78	CHEMBL4900	Homo sapiens	Inhibition	%	1.78
	8204564	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	34.87	CHEMBL4900	Homo sapiens	Inhibition	%	34.87
	8204669	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.67	CHEMBL4900	Homo sapiens	Inhibition	%	2.67
	8204893	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.33	CHEMBL4900	Homo sapiens	Inhibition	%	1.33
	8205008	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.63	CHEMBL4900	Homo sapiens	Inhibition	%	3.63
	8205381	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	52.4	CHEMBL4900	Homo sapiens	Inhibition	%	52.4
	8205517	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.9	CHEMBL4900	Homo sapiens	Inhibition	%	1.9
	8205880	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.89	CHEMBL4900	Homo sapiens	Inhibition	%	2.89
	8206012	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.1	CHEMBL4900	Homo sapiens	Inhibition	%	0.1
	8206236	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.1	CHEMBL4900	Homo sapiens	Inhibition	%	-2.1
	8206288	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.13	CHEMBL4900	Homo sapiens	Inhibition	%	5.13
	8206512	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.28	CHEMBL4900	Homo sapiens	Inhibition	%	0.28
	8206655	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.39	CHEMBL4900	Homo sapiens	Inhibition	%	-1.39
	8206835	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.15	CHEMBL4900	Homo sapiens	Inhibition	%	4.15
	8207059	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.95	CHEMBL4900	Homo sapiens	Inhibition	%	5.95
	8207185	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.33	CHEMBL4900	Homo sapiens	Inhibition	%	7.33
	8207539	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.19	CHEMBL4900	Homo sapiens	Inhibition	%	6.19
	8207671	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.98	CHEMBL4900	Homo sapiens	Inhibition	%	0.98
	8207895	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.29	CHEMBL4900	Homo sapiens	Inhibition	%	5.29
	8208040	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.4	CHEMBL4900	Homo sapiens	Inhibition	%	5.4
	8208396	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	44.84	CHEMBL4900	Homo sapiens	Inhibition	%	44.84
	8208562	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.02	CHEMBL4900	Homo sapiens	Inhibition	%	2.02
	8208919	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	Inhibition	%	4.0
	8209248	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.19	CHEMBL4900	Homo sapiens	Inhibition	%	1.19
	8209364	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.92	CHEMBL4900	Homo sapiens	Inhibition	%	2.92
	8209738	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.52	CHEMBL4900	Homo sapiens	Inhibition	%	1.52
	8209874	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.39	CHEMBL4900	Homo sapiens	Inhibition	%	1.39
	8210098	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.69	CHEMBL4900	Homo sapiens	Inhibition	%	2.69
	8210239	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.78	CHEMBL4900	Homo sapiens	Inhibition	%	3.78
	8210599	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.32	CHEMBL4900	Homo sapiens	Inhibition	%	-1.32
	8210858	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.8	CHEMBL4900	Homo sapiens	Inhibition	%	-0.8
	8211002	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.89	CHEMBL4900	Homo sapiens	Inhibition	%	4.89
	8211396	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.5	CHEMBL4900	Homo sapiens	Inhibition	%	4.5
	8211519	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	40.13	CHEMBL4900	Homo sapiens	Inhibition	%	40.13
	8211743	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.16	CHEMBL4900	Homo sapiens	Inhibition	%	3.16
	8211872	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.92	CHEMBL4900	Homo sapiens	Inhibition	%	5.92
	8212228	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.47	CHEMBL4900	Homo sapiens	Inhibition	%	5.47
	8212369	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.7	CHEMBL4900	Homo sapiens	Inhibition	%	2.7
	8212726	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.08	CHEMBL4900	Homo sapiens	Inhibition	%	5.08
	8212896	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.67	CHEMBL4900	Homo sapiens	Inhibition	%	6.67
	8213120	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.43	CHEMBL4900	Homo sapiens	Inhibition	%	1.43
	8213249	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.32	CHEMBL4900	Homo sapiens	Inhibition	%	18.32
	8213577	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.08	CHEMBL4900	Homo sapiens	Inhibition	%	-1.08
	8213690	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.27	CHEMBL4900	Homo sapiens	Inhibition	%	3.27
	8213914	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.55	CHEMBL4900	Homo sapiens	Inhibition	%	2.55
	8214061	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.5	CHEMBL4900	Homo sapiens	Inhibition	%	0.5
	8214422	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.06	CHEMBL4900	Homo sapiens	Inhibition	%	4.06
	8214556	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.15	CHEMBL4900	Homo sapiens	Inhibition	%	-0.15
	8214932	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	16.16	CHEMBL4900	Homo sapiens	Inhibition	%	16.16
	8215183	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.14	CHEMBL4900	Homo sapiens	Inhibition	%	5.14
	8215336	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.96	CHEMBL4900	Homo sapiens	Inhibition	%	5.96
	8215560	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.87	CHEMBL4900	Homo sapiens	Inhibition	%	4.87
	8215724	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.35	CHEMBL4900	Homo sapiens	Inhibition	%	5.35
	8216067	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	17.48	CHEMBL4900	Homo sapiens	Inhibition	%	17.48
	8216186	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.59	CHEMBL4900	Homo sapiens	Inhibition	%	3.59
	8216546	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.34	CHEMBL4900	Homo sapiens	Inhibition	%	6.34
	8216684	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.37	CHEMBL4900	Homo sapiens	Inhibition	%	4.37
	8216908	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.3	CHEMBL4900	Homo sapiens	Inhibition	%	0.3
	8217042	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.93	CHEMBL4900	Homo sapiens	Inhibition	%	7.93
	8217440	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.8	CHEMBL4900	Homo sapiens	Inhibition	%	3.8
	8217571	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.97	CHEMBL4900	Homo sapiens	Inhibition	%	3.97
	8217896	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.34	CHEMBL4900	Homo sapiens	Inhibition	%	-0.34
	8218235	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.37	CHEMBL4900	Homo sapiens	Inhibition	%	6.37
	8218362	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.5	CHEMBL4900	Homo sapiens	Inhibition	%	2.5
	8218586	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.33	CHEMBL4900	Homo sapiens	Inhibition	%	6.33
	8218729	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.37	CHEMBL4900	Homo sapiens	Inhibition	%	3.37
	8218860	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	10.08	CHEMBL4900	Homo sapiens	Inhibition	%	10.08
	8219084	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.12	CHEMBL4900	Homo sapiens	Inhibition	%	3.12
	8219244	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	80.67	CHEMBL4900	Homo sapiens	Inhibition	%	80.67
	8219494	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.5	CHEMBL4900	Homo sapiens	Inhibition	%	4.5
	8219879	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.47	CHEMBL4900	Homo sapiens	Inhibition	%	6.47
	8220048	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.37	CHEMBL4900	Homo sapiens	Inhibition	%	4.37
	8220401	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.45	CHEMBL4900	Homo sapiens	Inhibition	%	6.45
	8220515	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.08	CHEMBL4900	Homo sapiens	Inhibition	%	4.08
	8220739	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.43	CHEMBL4900	Homo sapiens	Inhibition	%	3.43
	8220877	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	15.45	CHEMBL4900	Homo sapiens	Inhibition	%	15.45
	8221237	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	17.44	CHEMBL4900	Homo sapiens	Inhibition	%	17.44
	8221370	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.65	CHEMBL4900	Homo sapiens	Inhibition	%	3.65
	8221594	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.66	CHEMBL4900	Homo sapiens	Inhibition	%	4.66
	8221759	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.35	CHEMBL4900	Homo sapiens	Inhibition	%	3.35
	8221890	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.79	CHEMBL4900	Homo sapiens	Inhibition	%	4.79
	8222114	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.56	CHEMBL4900	Homo sapiens	Inhibition	%	4.56
	8222212	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.04	CHEMBL4900	Homo sapiens	Inhibition	%	2.04
	8222570	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.92	CHEMBL4900	Homo sapiens	Inhibition	%	2.92
	8222912	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.82	CHEMBL4900	Homo sapiens	Inhibition	%	2.82
	8223056	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.15	CHEMBL4900	Homo sapiens	Inhibition	%	3.15
	8223409	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.25	CHEMBL4900	Homo sapiens	Inhibition	%	4.25
	8223570	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.07	CHEMBL4900	Homo sapiens	Inhibition	%	-0.07
	8223820	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.88	CHEMBL4900	Homo sapiens	Inhibition	%	4.88
	8224044	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.27	CHEMBL4900	Homo sapiens	Inhibition	%	4.27
	8224206	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.95	CHEMBL4900	Homo sapiens	Inhibition	%	2.95
	8224376	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.96	CHEMBL4900	Homo sapiens	Inhibition	%	3.96
	8224600	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.73	CHEMBL4900	Homo sapiens	Inhibition	%	3.73
	8224735	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.88	CHEMBL4900	Homo sapiens	Inhibition	%	5.88
	8225073	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.46	CHEMBL4900	Homo sapiens	Inhibition	%	7.46
	8225207	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.45	CHEMBL4900	Homo sapiens	Inhibition	%	5.45
	8225431	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.41	CHEMBL4900	Homo sapiens	Inhibition	%	7.41
	8225569	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.94	CHEMBL4900	Homo sapiens	Inhibition	%	1.94
	8225928	CHEMBL1961914	GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.86	CHEMBL4900	Homo sapiens	Inhibition	%	3.86
	8226086	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	38.26	CHEMBL4900	Homo sapiens	Inhibition	%	38.26
	8226435	CHEMBL1961915	GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.62	CHEMBL4900	Homo sapiens	Inhibition	%	5.62
active	9545307	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9545308	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545309	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545310	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9545311	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545312	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	79.43	CHEMBL4900	Homo sapiens	pKi		7.1
active	9545313	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9545314	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9545315	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545316	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545317	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9545318	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9545319	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545320	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9545321	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9545322	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	25.12	CHEMBL4900	Homo sapiens	pKi		7.6
inactive	9545323	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545324	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9545325	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545326	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9545327	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545328	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545329	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	39.81	CHEMBL4900	Homo sapiens	pKi		7.4
inactive	9545330	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545331	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9545332	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9545333	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545334	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	19.95	CHEMBL4900	Homo sapiens	pKi		7.7
active	9545335	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9545336	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545337	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	12.59	CHEMBL4900	Homo sapiens	pKi		7.9
active	9545338	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9545339	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9545340	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545341	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9545342	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545343	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9545344	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
inactive	9545345	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545346	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545347	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545348	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545349	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
active	9545350	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9545351	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545352	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545353	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545354	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545355	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
active	9545356	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9545357	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9545358	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	7.943	CHEMBL4900	Homo sapiens	pKi		8.1
inactive	9545359	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545360	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545361	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9545362	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545363	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	7.943	CHEMBL4900	Homo sapiens	pKi		8.1
inactive	9545364	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545365	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545366	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545367	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9545368	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545369	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545370	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545371	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545372	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545373	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
active	9545374	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
inactive	9545375	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545376	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545377	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545378	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9545379	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545380	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545381	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9545382	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9545383	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545384	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545385	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545386	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
inactive	9545387	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545388	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545389	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9545390	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
active	9545391	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9545392	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545393	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9545394	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9545395	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9545396	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9545397	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545398	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9545399	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545400	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
active	9545401	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9545402	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9545403	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9545404	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9545405	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545406	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9545407	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9545408	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545409	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545410	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545411	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545412	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545413	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9545414	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9545415	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545416	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545417	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9545418	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545419	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545420	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545421	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9545422	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545423	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545424	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545425	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	79.43	CHEMBL4900	Homo sapiens	pKi		7.1
inactive	9545426	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545427	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545428	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545429	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545430	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545431	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545432	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545433	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545434	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9545435	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9545436	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545437	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9545438	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9545439	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545440	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9545441	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545442	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9545443	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545444	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545445	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9545446	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545447	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545448	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9545449	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9545450	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545451	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545452	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545453	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545454	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545455	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9545456	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9545457	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545458	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545459	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545460	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9545461	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545462	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9545463	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545464	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545465	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9545466	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545467	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9545468	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9545469	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545470	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
active	9545471	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9545472	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9545473	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9545474	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545475	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9545476	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545477	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545478	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545479	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545480	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9545481	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	6.31	CHEMBL4900	Homo sapiens	pKi		8.2
inactive	9545482	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545483	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9545484	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9545485	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
inactive	9545486	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545487	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545488	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545489	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545490	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1ccc(CO)cc1)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1974363	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545491	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545492	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9545493	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545494	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545495	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545496	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9545497	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545498	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9545499	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545500	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9545501	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545502	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
active	9545503	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9545504	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545505	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545506	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9545507	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545508	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545509	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545510	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545511	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545512	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	2.512	CHEMBL4900	Homo sapiens	pKi		8.6
active	9545513	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9545514	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9545515	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9545516	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9545517	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9545518	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9545519	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9545520	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549413	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549414	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549415	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549416	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9549417	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549418	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549419	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549420	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549421	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9549422	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
active	9549423	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549424	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549425	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549426	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549427	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549428	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549429	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549430	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549431	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549432	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549433	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549434	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549435	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549436	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549437	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549438	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549439	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549440	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549441	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9549442	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549443	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549444	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9549445	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9549446	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9549447	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549448	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549449	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549450	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549451	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549452	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549453	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549454	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549455	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549456	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549457	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549458	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549459	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549460	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549461	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549462	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549463	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549464	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549465	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549466	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549467	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549468	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549469	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549470	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549471	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549472	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549473	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549474	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9549475	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549476	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549477	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549478	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9549479	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549480	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	158.49	CHEMBL4900	Homo sapiens	pKi		6.8
active	9549481	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549482	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549483	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549484	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549485	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	79.43	CHEMBL4900	Homo sapiens	pKi		7.1
active	9549486	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	158.49	CHEMBL4900	Homo sapiens	pKi		6.8
active	9549487	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549488	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549489	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549490	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549491	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549492	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549493	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549494	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9549495	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549496	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549497	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	63.1	CHEMBL4900	Homo sapiens	pKi		7.2
active	9549498	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549499	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549500	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549501	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9549502	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549503	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549504	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549505	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549506	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9549507	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549508	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549509	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549510	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9549511	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549512	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549513	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549514	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
inactive	9549515	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549516	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549517	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549518	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549519	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549520	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549521	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
active	9549522	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549523	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549524	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549525	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549526	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549527	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549528	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549529	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	79.43	CHEMBL4900	Homo sapiens	pKi		7.1
active	9549530	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9549531	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549532	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549533	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9549534	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9549535	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9549536	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549537	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	50.12	CHEMBL4900	Homo sapiens	pKi		7.3
inactive	9549538	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549539	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549540	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9549541	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9549542	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549543	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549544	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549545	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549546	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549547	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549548	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549549	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549550	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549551	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549552	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549553	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549554	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549555	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9549556	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549557	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549558	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549559	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549560	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549561	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549562	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549563	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549564	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549565	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
inactive	9549566	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549567	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1ccc2c(-c3ccccc3F)nc(N(C(N)=O)c3c(F)cccc3F)nc21		CHEMBL1981723	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549568	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549569	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549570	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9549571	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549572	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549573	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549574	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549575	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9549576	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549577	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
active	9549578	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	50.12	CHEMBL4900	Homo sapiens	pKi		7.3
inactive	9549579	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549580	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9549581	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549582	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549583	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549584	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9549585	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549586	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9549587	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549588	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549589	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549590	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	19.95	CHEMBL4900	Homo sapiens	pKi		7.7
active	9549591	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9549592	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9549593	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549594	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549595	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9549596	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549597	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549598	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
active	9549599	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
inactive	9549600	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549601	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549602	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549603	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549604	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549605	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549606	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549607	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549608	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9549609	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549610	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9549611	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549612	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549613	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549614	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549615	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
active	9549616	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9549617	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
active	9549618	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9549619	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9549620	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549621	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9549622	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9549623	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549624	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549625	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549626	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549627	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549628	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549629	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549630	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549631	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549632	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549633	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	50.12	CHEMBL4900	Homo sapiens	pKi		7.3
inactive	9549634	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549635	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549636	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	25.12	CHEMBL4900	Homo sapiens	pKi		7.6
active	9549637	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9549638	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549639	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
active	9549640	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9549641	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549642	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549643	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9549644	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
active	9549645	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
inactive	9549646	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549647	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	=	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549648	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9549649	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9549650	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9549651	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9549652	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553545	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553546	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553547	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553548	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9553549	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
inactive	9553550	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553551	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553552	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9553553	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553554	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1		CHEMBL365617	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553555	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9553556	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553557	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553558	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553559	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553560	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553561	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553562	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553563	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553564	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553565	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553566	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553567	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9553568	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553569	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
inactive	9553570	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553571	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9553572	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553573	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
inactive	9553574	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553575	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
active	9553576	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553577	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553578	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553579	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553580	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553581	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9553582	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553583	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553584	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553585	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553586	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553587	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9553588	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553589	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9553590	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553591	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553592	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553593	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553594	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553595	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553596	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
active	9553597	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	39.81	CHEMBL4900	Homo sapiens	pKi		7.4
active	9553598	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9553599	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9553600	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	31.62	CHEMBL4900	Homo sapiens	pKi		7.5
inactive	9553601	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553602	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
active	9553603	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9553604	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553605	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553606	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9553607	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9553608	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553609	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
inactive	9553610	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553611	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553612	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553613	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553614	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553615	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553616	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553617	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553618	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553619	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553620	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	15.85	CHEMBL4900	Homo sapiens	pKi		7.8
inactive	9553621	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553622	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553623	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553624	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553625	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553626	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553627	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553628	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553629	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553630	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9553631	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553632	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553633	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553634	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
active	9553635	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	pKi		6.0
active	9553636	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
inactive	9553637	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553638	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	31.62	CHEMBL4900	Homo sapiens	pKi		7.5
active	9553639	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9553640	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9553641	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553642	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553643	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553644	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553645	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553646	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553647	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553648	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9553649	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553650	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553651	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9553652	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553653	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553654	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553655	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9553656	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553657	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553658	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
inactive	9553659	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553660	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553661	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9553662	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9553663	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9553664	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9553665	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553666	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	12.59	CHEMBL4900	Homo sapiens	pKi		7.9
inactive	9553667	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553668	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9553669	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553670	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553671	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553672	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
active	9553673	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	50.12	CHEMBL4900	Homo sapiens	pKi		7.3
inactive	9553674	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553675	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553676	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553677	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553678	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	199.53	CHEMBL4900	Homo sapiens	pKi		6.7
active	9553679	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
active	9553680	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553681	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553682	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553683	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553684	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	158.49	CHEMBL4900	Homo sapiens	pKi		6.8
inactive	9553685	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553686	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
inactive	9553687	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553688	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553689	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9553690	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553691	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553692	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553693	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553694	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
active	9553695	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9553696	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553697	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
active	9553698	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
active	9553699	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9553700	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553701	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553702	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553703	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553704	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553705	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9553706	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9553707	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553708	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9553709	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553710	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553711	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553712	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
active	9553713	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553714	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553715	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553716	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553717	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553718	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553719	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553720	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553721	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553722	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553723	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553724	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553725	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	19.95	CHEMBL4900	Homo sapiens	pKi		7.7
inactive	9553726	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553727	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
inactive	9553728	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553729	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9553730	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
active	9553731	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
active	9553732	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553733	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553734	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	15.85	CHEMBL4900	Homo sapiens	pKi		7.8
active	9553735	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553736	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9553737	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	31.62	CHEMBL4900	Homo sapiens	pKi		7.5
inactive	9553738	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553739	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553740	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553741	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553742	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	251.19	CHEMBL4900	Homo sapiens	pKi		6.6
active	9553743	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
active	9553744	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9553745	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553746	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553747	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553748	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553749	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	39.81	CHEMBL4900	Homo sapiens	pKi		7.4
inactive	9553750	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553751	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9553752	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553753	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9553754	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553755	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553756	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553757	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	=	Ki	nM	50.12	CHEMBL4900	Homo sapiens	pKi		7.3
active	9553758	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	630.96	CHEMBL4900	Homo sapiens	pKi		6.2
active	9553759	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
active	9553760	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9553761	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553762	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
active	9553763	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553764	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553765	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553766	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553767	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553768	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL4900	Homo sapiens	pKi		5.2
active	9553769	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	398.11	CHEMBL4900	Homo sapiens	pKi		6.4
inactive	9553770	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
inactive	9553771	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553772	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9553773	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553774	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553775	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553776	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553777	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553778	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553779	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9553780	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9553781	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9553782	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9553783	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557692	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
active	9557693	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	5011.87	CHEMBL4900	Homo sapiens	pKi		5.3
active	9557694	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9557695	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557696	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
active	9557697	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	316.23	CHEMBL4900	Homo sapiens	pKi		6.5
active	9557698	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
inactive	9557699	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557700	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557701	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	=	Ki	nM	7943.28	CHEMBL4900	Homo sapiens	pKi		5.1
inactive	9557702	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557703	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557704	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557705	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557706	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557707	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
active	9557708	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9557709	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557710	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9557711	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557712	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557713	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557714	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557715	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557716	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557717	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	2511.89	CHEMBL4900	Homo sapiens	pKi		5.6
inactive	9557718	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557719	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557720	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557721	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557722	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
active	9557723	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	=	Ki	nM	794.33	CHEMBL4900	Homo sapiens	pKi		6.1
inactive	9557724	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557725	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557726	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557727	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557728	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557729	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	79.43	CHEMBL4900	Homo sapiens	pKi		7.1
active	9557730	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	1995.26	CHEMBL4900	Homo sapiens	pKi		5.7
inactive	9557731	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557732	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	1584.89	CHEMBL4900	Homo sapiens	pKi		5.8
inactive	9557733	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557734	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557735	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	501.19	CHEMBL4900	Homo sapiens	pKi		6.3
inactive	9557736	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557737	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557738	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	1258.93	CHEMBL4900	Homo sapiens	pKi		5.9
inactive	9557739	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557740	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	125.89	CHEMBL4900	Homo sapiens	pKi		6.9
inactive	9557741	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557742	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	100.0	CHEMBL4900	Homo sapiens	pKi		7.0
active	9557743	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	3162.28	CHEMBL4900	Homo sapiens	pKi		5.5
inactive	9557744	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557745	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
inactive	9557746	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	10000.0	CHEMBL4900	Homo sapiens	pKi		5.0
active	9557747	CHEMBL1963707	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	3981.07	CHEMBL4900	Homo sapiens	pKi		5.4
	10839465	CHEMBL2015496	Inhibition of PKD2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	84.0	CHEMBL4900	Homo sapiens	INH	%	84.0
	10923948	CHEMBL2044163	Inhibition of PKD2 incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	330.0	CHEMBL4900	Homo sapiens	IC50	uM	0.33
	10923968	CHEMBL2044162	Inhibition of PKD2 at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	77.0	CHEMBL4900	Homo sapiens	INH	%	77.0
Active	12037014	CHEMBL2149977	Inhibition of PKD2 at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	12047323	CHEMBL2157434	Inhibition of PKD2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	1.6	CHEMBL4900	Homo sapiens	INH	%	1.6
	12172247	CHEMBL2212477	Inhibition of PRKD2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	74.0	CHEMBL4900	Homo sapiens	Activity	%	74.0
	12183825	CHEMBL2214435	Inhibition of PRKD2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	pIC50		5.0
	12188413	CHEMBL2211134	Binding affinity to PKD2	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL4900	Homo sapiens	Activity	%	50.0
	12195423	CHEMBL2209631	Inhibition of recombinant PKD2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	175.0	CHEMBL4900	Homo sapiens	Ki	nM	175.0
	12259039	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259040	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259041	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12259042	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259043	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12259044	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12259045	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259046	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12259047	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259048	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12259049	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12259050	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12259051	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12259052	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	80.0	CHEMBL4900	Homo sapiens	Residual Activity	%	80.0
	12259053	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	85.0	CHEMBL4900	Homo sapiens	Residual Activity	%	85.0
	12259054	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12259055	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12259056	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259057	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259058	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	40.0	CHEMBL4900	Homo sapiens	Residual Activity	%	40.0
	12259059	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12259060	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259061	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12259062	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12259063	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259064	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12259065	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259066	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12259067	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259068	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259069	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259070	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12259071	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259072	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259073	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259074	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12259075	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12259076	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259077	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259078	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259079	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12259080	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12259081	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	29.0	CHEMBL4900	Homo sapiens	Residual Activity	%	29.0
	12259082	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	25.0	CHEMBL4900	Homo sapiens	Residual Activity	%	25.0
	12259083	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259084	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12259085	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12259086	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12259087	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259088	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12259089	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12259090	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12259091	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	30.0	CHEMBL4900	Homo sapiens	Residual Activity	%	30.0
	12259092	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259093	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12259094	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12259095	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259096	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259097	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12259098	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259099	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12259100	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259101	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259102	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259103	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12259104	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259105	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259106	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12259107	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12259108	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12259109	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12259110	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12259111	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12259112	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12259113	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259114	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12259115	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12259116	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	73.0	CHEMBL4900	Homo sapiens	Residual Activity	%	73.0
	12259117	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259118	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	5.0	CHEMBL4900	Homo sapiens	Residual Activity	%	5.0
	12259119	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259120	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	113.0	CHEMBL4900	Homo sapiens	Residual Activity	%	113.0
	12259121	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12259122	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	89.0	CHEMBL4900	Homo sapiens	Residual Activity	%	89.0
	12259123	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12259124	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12259125	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12259126	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12259127	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12259128	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	109.0	CHEMBL4900	Homo sapiens	Residual Activity	%	109.0
	12259129	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12259130	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12259131	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12259132	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	111.0	CHEMBL4900	Homo sapiens	Residual Activity	%	111.0
	12259133	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12259134	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259135	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12259136	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12259137	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260780	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260781	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	90.0	CHEMBL4900	Homo sapiens	Residual Activity	%	90.0
	12260782	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4900	Homo sapiens	Residual Activity	%	2.0
	12260783	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260784	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12260785	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260786	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260787	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260788	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260789	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260790	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260791	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260792	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260793	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260794	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260795	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260796	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260797	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260798	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260799	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260800	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260801	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260802	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260803	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260804	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260805	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260806	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260807	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260808	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260809	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260810	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	45.0	CHEMBL4900	Homo sapiens	Residual Activity	%	45.0
	12260811	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260812	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260813	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12260814	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260815	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260816	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260817	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260818	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260819	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260820	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260821	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	109.0	CHEMBL4900	Homo sapiens	Residual Activity	%	109.0
	12260822	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260823	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260824	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12260825	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260826	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12260827	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260828	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260829	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260830	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260831	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260832	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260833	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260834	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260835	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260836	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260837	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260838	CHEMBL2219121	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	101.0	CHEMBL4900	Homo sapiens	Residual Activity	%	101.0
	12260839	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260840	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260841	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260842	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260843	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260844	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	109.0	CHEMBL4900	Homo sapiens	Residual Activity	%	109.0
	12260845	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260846	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260847	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260848	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	116.0	CHEMBL4900	Homo sapiens	Residual Activity	%	116.0
	12260849	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260850	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260851	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	112.0	CHEMBL4900	Homo sapiens	Residual Activity	%	112.0
	12260852	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	24.0	CHEMBL4900	Homo sapiens	Residual Activity	%	24.0
	12260853	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	29.0	CHEMBL4900	Homo sapiens	Residual Activity	%	29.0
	12260854	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260855	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260856	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260857	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260858	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	22.0	CHEMBL4900	Homo sapiens	Residual Activity	%	22.0
	12260859	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260860	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	89.0	CHEMBL4900	Homo sapiens	Residual Activity	%	89.0
	12260861	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260862	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260863	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL4900	Homo sapiens	Residual Activity	%	111.0
	12260864	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	113.0	CHEMBL4900	Homo sapiens	Residual Activity	%	113.0
	12260865	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	87.0	CHEMBL4900	Homo sapiens	Residual Activity	%	87.0
	12260866	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	79.0	CHEMBL4900	Homo sapiens	Residual Activity	%	79.0
	12260867	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260868	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260869	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	66.0	CHEMBL4900	Homo sapiens	Residual Activity	%	66.0
	12260870	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260871	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260872	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12260873	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260874	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260875	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260876	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260877	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260878	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260879	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL4900	Homo sapiens	Residual Activity	%	109.0
	12260880	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL4900	Homo sapiens	Residual Activity	%	109.0
	12260881	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	32.0	CHEMBL4900	Homo sapiens	Residual Activity	%	32.0
	12260882	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL4900	Homo sapiens	Residual Activity	%	4.0
	12260883	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260884	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260885	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260886	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260887	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260888	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260889	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260890	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12260891	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	3.0	CHEMBL4900	Homo sapiens	Residual Activity	%	3.0
	12260892	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	108.0	CHEMBL4900	Homo sapiens	Residual Activity	%	108.0
	12260893	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260894	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260895	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260896	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	119.0	CHEMBL4900	Homo sapiens	Residual Activity	%	119.0
	12260897	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260898	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260899	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	56.0	CHEMBL4900	Homo sapiens	Residual Activity	%	56.0
	12260900	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12260901	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260902	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260903	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	91.0	CHEMBL4900	Homo sapiens	Residual Activity	%	91.0
	12260904	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260905	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260906	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	114.0	CHEMBL4900	Homo sapiens	Residual Activity	%	114.0
	12260907	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260908	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL4900	Homo sapiens	Residual Activity	%	106.0
	12260909	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	110.0	CHEMBL4900	Homo sapiens	Residual Activity	%	110.0
	12260910	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260911	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	82.0	CHEMBL4900	Homo sapiens	Residual Activity	%	82.0
	12260912	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260913	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	83.0	CHEMBL4900	Homo sapiens	Residual Activity	%	83.0
	12260914	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	90.0	CHEMBL4900	Homo sapiens	Residual Activity	%	90.0
	12260915	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260916	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	16.0	CHEMBL4900	Homo sapiens	Residual Activity	%	16.0
	12260917	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260918	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL4900	Homo sapiens	Residual Activity	%	-1.0
	12260919	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	79.0	CHEMBL4900	Homo sapiens	Residual Activity	%	79.0
	12260920	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	78.0	CHEMBL4900	Homo sapiens	Residual Activity	%	78.0
	12260921	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	90.0	CHEMBL4900	Homo sapiens	Residual Activity	%	90.0
	12260922	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	112.0	CHEMBL4900	Homo sapiens	Residual Activity	%	112.0
	12260923	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL4900	Homo sapiens	Residual Activity	%	107.0
	12260924	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260925	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12260926	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL4900	Homo sapiens	Residual Activity	%	90.0
	12260927	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	103.0	CHEMBL4900	Homo sapiens	Residual Activity	%	103.0
	12260928	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260929	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	84.0	CHEMBL4900	Homo sapiens	Residual Activity	%	84.0
	12260930	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	49.0	CHEMBL4900	Homo sapiens	Residual Activity	%	49.0
	12260931	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260932	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12260933	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	73.0	CHEMBL4900	Homo sapiens	Residual Activity	%	73.0
	12260934	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	88.0	CHEMBL4900	Homo sapiens	Residual Activity	%	88.0
	12260935	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260936	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260937	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL4900	Homo sapiens	Residual Activity	%	85.0
	12260938	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260939	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	42.0	CHEMBL4900	Homo sapiens	Residual Activity	%	42.0
	12260940	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL4900	Homo sapiens	Residual Activity	%	0.0
	12260941	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260942	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL4900	Homo sapiens	Residual Activity	%	90.0
	12260943	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12260944	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260945	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	70.0	CHEMBL4900	Homo sapiens	Residual Activity	%	70.0
	12260946	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260947	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	105.0	CHEMBL4900	Homo sapiens	Residual Activity	%	105.0
	12260948	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	86.0	CHEMBL4900	Homo sapiens	Residual Activity	%	86.0
	12260949	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12260950	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	94.0	CHEMBL4900	Homo sapiens	Residual Activity	%	94.0
	12260951	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260952	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260953	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	84.0	CHEMBL4900	Homo sapiens	Residual Activity	%	84.0
	12260954	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260955	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	64.0	CHEMBL4900	Homo sapiens	Residual Activity	%	64.0
	12260956	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260957	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	49.0	CHEMBL4900	Homo sapiens	Residual Activity	%	49.0
	12260958	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	89.0	CHEMBL4900	Homo sapiens	Residual Activity	%	89.0
	12260959	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260960	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260961	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260962	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260963	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	76.0	CHEMBL4900	Homo sapiens	Residual Activity	%	76.0
	12260964	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260965	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	98.0	CHEMBL4900	Homo sapiens	Residual Activity	%	98.0
	12260966	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260967	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260968	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	6.0	CHEMBL4900	Homo sapiens	Residual Activity	%	6.0
	12260969	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260970	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260971	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	36.0	CHEMBL4900	Homo sapiens	Residual Activity	%	36.0
	12260972	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260973	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	54.0	CHEMBL4900	Homo sapiens	Residual Activity	%	54.0
	12260974	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	99.0	CHEMBL4900	Homo sapiens	Residual Activity	%	99.0
	12260975	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL4900	Homo sapiens	Residual Activity	%	87.0
	12260976	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	51.0	CHEMBL4900	Homo sapiens	Residual Activity	%	51.0
	12260977	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	95.0	CHEMBL4900	Homo sapiens	Residual Activity	%	95.0
	12260978	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL4900	Homo sapiens	Residual Activity	%	92.0
	12260979	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	100.0	CHEMBL4900	Homo sapiens	Residual Activity	%	100.0
	12260980	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	80.0	CHEMBL4900	Homo sapiens	Residual Activity	%	80.0
	12260981	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	84.0	CHEMBL4900	Homo sapiens	Residual Activity	%	84.0
	12260982	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	91.0	CHEMBL4900	Homo sapiens	Residual Activity	%	91.0
	12260983	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	87.0	CHEMBL4900	Homo sapiens	Residual Activity	%	87.0
	12260984	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	91.0	CHEMBL4900	Homo sapiens	Residual Activity	%	91.0
	12260985	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260986	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	82.0	CHEMBL4900	Homo sapiens	Residual Activity	%	82.0
	12260987	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	89.0	CHEMBL4900	Homo sapiens	Residual Activity	%	89.0
	12260988	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	96.0	CHEMBL4900	Homo sapiens	Residual Activity	%	96.0
	12260989	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	39.0	CHEMBL4900	Homo sapiens	Residual Activity	%	39.0
	12260990	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL4900	Homo sapiens	Residual Activity	%	97.0
	12260991	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260992	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	104.0	CHEMBL4900	Homo sapiens	Residual Activity	%	104.0
	12260993	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL4900	Homo sapiens	Residual Activity	%	93.0
	12260994	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	102.0	CHEMBL4900	Homo sapiens	Residual Activity	%	102.0
	12260995	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	81.0	CHEMBL4900	Homo sapiens	Residual Activity	%	81.0
	12260996	CHEMBL2219122	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	91.0	CHEMBL4900	Homo sapiens	Residual Activity	%	91.0
	12647875	CHEMBL2329061	Inhibition of PKD2 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	INH	%	-1.0
	12647876	CHEMBL2329061	Inhibition of PKD2 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	13.0	CHEMBL4900	Homo sapiens	INH	%	13.0
	12647877	CHEMBL2329061	Inhibition of PKD2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	-1.0	CHEMBL4900	Homo sapiens	INH	%	-1.0
	12647878	CHEMBL2329061	Inhibition of PKD2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	76.0	CHEMBL4900	Homo sapiens	INH	%	76.0
	12649567	CHEMBL2329522	Inhibition of PKD2 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	48.0	CHEMBL4900	Homo sapiens	INH	%	48.0
	12649568	CHEMBL2329522	Inhibition of PKD2 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	75.0	CHEMBL4900	Homo sapiens	INH	%	75.0
	12649569	CHEMBL2329522	Inhibition of PKD2 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	82.0	CHEMBL4900	Homo sapiens	INH	%	82.0
	12693183	CHEMBL2343426	Inhibition of PKD2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	nM	10000.0
	12727680	CHEMBL2351393	Inhibition of PKD2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	92.0	CHEMBL4900	Homo sapiens	Activity	%	92.0
	12728966	CHEMBL2349900	Inhibition of PKD2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL4900	Homo sapiens	Activity	%	92.0
	12729847	CHEMBL2352432	Inhibition of PKD2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL4900	Homo sapiens	Activity	%	98.0
	12730109	CHEMBL2351393	Inhibition of PKD2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	107.0	CHEMBL4900	Homo sapiens	Activity	%	107.0
	13281293	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	6.0	CHEMBL4900	Homo sapiens	INH	%	6.0
	13281294	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	13281295	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	16.0	CHEMBL4900	Homo sapiens	INH	%	16.0
	13281296	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	13281297	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-2.0	CHEMBL4900	Homo sapiens	INH	%	-2.0
	13281298	CHEMBL2378207	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	13374372	CHEMBL2406504	Inhibition of PKD2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	7.0	CHEMBL4900	Homo sapiens	INH	%	7.0
	13414660	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414661	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414662	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414663	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414664	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414665	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414666	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414667	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13414668	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	=	Inhibition	%	51.7	CHEMBL4900	Homo sapiens	INH	%	51.7
	13414669	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13415493	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	85.0	CHEMBL4900	Homo sapiens	INH	%	85.0
	13415494	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	27.0	CHEMBL4900	Homo sapiens	INH	%	27.0
	13415495	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	30.0	CHEMBL4900	Homo sapiens	INH	%	30.0
	13415496	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13415497	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	45.0	CHEMBL4900	Homo sapiens	INH	%	45.0
	13415498	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	44.0	CHEMBL4900	Homo sapiens	INH	%	44.0
	13415499	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	36.0	CHEMBL4900	Homo sapiens	INH	%	36.0
	13415500	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	33.0	CHEMBL4900	Homo sapiens	INH	%	33.0
	13415501	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	30.0	CHEMBL4900	Homo sapiens	INH	%	30.0
	13415502	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	84.0	CHEMBL4900	Homo sapiens	INH	%	84.0
	13415503	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	71.0	CHEMBL4900	Homo sapiens	INH	%	71.0
	13415504	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	38.0	CHEMBL4900	Homo sapiens	INH	%	38.0
	13415505	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	13415506	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	64.0	CHEMBL4900	Homo sapiens	INH	%	64.0
	13415507	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	48.0	CHEMBL4900	Homo sapiens	INH	%	48.0
	13415508	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	13415509	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	40.0	CHEMBL4900	Homo sapiens	INH	%	40.0
	13415510	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	13415511	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	2.0	CHEMBL4900	Homo sapiens	INH	%	2.0
	13415512	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	18.0	CHEMBL4900	Homo sapiens	INH	%	18.0
	13415513	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	21.0	CHEMBL4900	Homo sapiens	INH	%	21.0
	13415514	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	19.0	CHEMBL4900	Homo sapiens	INH	%	19.0
	13415515	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	15.0	CHEMBL4900	Homo sapiens	INH	%	15.0
	13415516	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	81.0	CHEMBL4900	Homo sapiens	INH	%	81.0
	13415517	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	24.0	CHEMBL4900	Homo sapiens	INH	%	24.0
	13415518	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	16.0	CHEMBL4900	Homo sapiens	INH	%	16.0
	13415519	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	13415520	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	7.0	CHEMBL4900	Homo sapiens	INH	%	7.0
	13415521	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	55.0	CHEMBL4900	Homo sapiens	INH	%	55.0
	13415522	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	13415523	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	91.0	CHEMBL4900	Homo sapiens	INH	%	91.0
	13415524	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	82.0	CHEMBL4900	Homo sapiens	INH	%	82.0
	13415525	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	42.0	CHEMBL4900	Homo sapiens	INH	%	42.0
	13415526	CHEMBL2424330	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	53.0	CHEMBL4900	Homo sapiens	INH	%	53.0
	13420987	CHEMBL2424123	Inhibition of PKD2 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	1300.0	CHEMBL4900	Homo sapiens	IC50	uM	1.3
	13420988	CHEMBL2424123	Inhibition of PKD2 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	IC50	nM	46000.0	CHEMBL4900	Homo sapiens	IC50	uM	46.0
	13438380	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13438381	CHEMBL2422680	Inhibition of PKD2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	13439770	CHEMBL2429010	Competitive binding affinity to PRKD2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	88.0	CHEMBL4900	Homo sapiens	INH	%	88.0
	13445603	CHEMBL2429010	Competitive binding affinity to PRKD2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	91.0	CHEMBL4900	Homo sapiens	INH	%	91.0
	13451590	CHEMBL2429010	Competitive binding affinity to PRKD2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	98.0	CHEMBL4900	Homo sapiens	INH	%	98.0
Not Active	13863520	CHEMBL3101993	Inhibition of PRKD2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Not Active	13863521	CHEMBL3101993	Inhibition of PRKD2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	13871770	CHEMBL3101124	Inhibition of human PKD2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	13966027	CHEMBL3136515	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	49.5	CHEMBL4900	Homo sapiens	INH	%	49.5
	13973302	CHEMBL3136895	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	13974020	CHEMBL3136484	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	13974111	CHEMBL3135622	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	68.0	CHEMBL4900	Homo sapiens	INH	%	68.0
	13974202	CHEMBL3134734	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	93.0	CHEMBL4900	Homo sapiens	INH	%	93.0
	13974293	CHEMBL3136845	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	70.0	CHEMBL4900	Homo sapiens	INH	%	70.0
	13975031	CHEMBL3135991	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	6.0	CHEMBL4900	Homo sapiens	INH	%	6.0
	13975122	CHEMBL3135718	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	1.5	CHEMBL4900	Homo sapiens	INH	%	1.5
	13975213	CHEMBL3135802	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	6.5	CHEMBL4900	Homo sapiens	INH	%	6.5
	13975856	CHEMBL3135471	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	28.5	CHEMBL4900	Homo sapiens	INH	%	28.5
	13975949	CHEMBL3137003	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	13.0	CHEMBL4900	Homo sapiens	INH	%	13.0
	13976040	CHEMBL3135396	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	77.5	CHEMBL4900	Homo sapiens	INH	%	77.5
	13976131	CHEMBL3136921	Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	77.5	CHEMBL4900	Homo sapiens	INH	%	77.5
	14585304	CHEMBL3241820	Inhibition of human PKD2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	95.5	CHEMBL4900	Homo sapiens	Activity	%	95.5
	14590408	CHEMBL3241995	Inhibition of PRKD2 (unknown origin) at 5 uM	B	Clc1nc(Cl)c2sccc2n1		CHEMBL3236403	<	Inhibition	%	40.0	CHEMBL4900	Homo sapiens	INH	%	40.0
	14664299	CHEMBL3271259	Inhibition of PRKD2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	99.0	CHEMBL4900	Homo sapiens	INH	%	99.0
	14664300	CHEMBL3271259	Inhibition of PRKD2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	92.0	CHEMBL4900	Homo sapiens	INH	%	92.0
	14664301	CHEMBL3271259	Inhibition of PRKD2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	77.0	CHEMBL4900	Homo sapiens	INH	%	77.0
	15018674	CHEMBL3361566	Inhibition of PKD2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	45.3	CHEMBL4900	Homo sapiens	INH	%	45.3
	15146836	CHEMBL3395663	Inhibition of PKD2 (unknown origin) at 1 uM	B	Nc1ncc(-c2ccc3[nH]nc(-c4cnc5ccccc5c4)c3c2)s1		CHEMBL3394059	>	Inhibition	%	90.0	CHEMBL4900	Homo sapiens	INH	%	90.0
	15191043	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	15191044	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	15191045	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	15191046	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	15191047	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	22.0	CHEMBL4900	Homo sapiens	INH	%	22.0
	15191048	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	15191049	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	67.0	CHEMBL4900	Homo sapiens	INH	%	67.0
	15191050	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	8.0	CHEMBL4900	Homo sapiens	INH	%	8.0
	15191051	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	9.0	CHEMBL4900	Homo sapiens	INH	%	9.0
	15191052	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	15191053	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	15191054	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	14.0	CHEMBL4900	Homo sapiens	INH	%	14.0
	15191055	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	15191056	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	22.0	CHEMBL4900	Homo sapiens	INH	%	22.0
	15191057	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	5.0	CHEMBL4900	Homo sapiens	INH	%	5.0
	15191058	CHEMBL3412795	Inhibition of PKD2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	67.0	CHEMBL4900	Homo sapiens	INH	%	67.0
	15735984	CHEMBL3624364	Inhibition of human recombinant PKD2	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	uM	10.0
	15742900	CHEMBL3626287	Inhibition of PRKD2 (unknown origin) at 1 uM	B	O=C(C1CC1)n1ccc2c3c(=O)cc(-c4ccccc4)[nH]c3ccc21		CHEMBL3623601	=	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	15756845	CHEMBL3630938	Inhibition of PKD2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	21.16	CHEMBL4900	Homo sapiens	INH	%	21.16
	15757878	CHEMBL3630938	Inhibition of PKD2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	101.62	CHEMBL4900	Homo sapiens	INH	%	101.62
	15758857	CHEMBL3630938	Inhibition of PKD2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	19.77	CHEMBL4900	Homo sapiens	INH	%	19.77
	16376476	CHEMBL3734500	Inhibition of recombinant human PKD2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	0.0	CHEMBL4900	Homo sapiens	INH	%	0.0
	16379691	CHEMBL3739162	Inhibition of PKD2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	31.6	CHEMBL4900	Homo sapiens	INH	%	31.6
	16379692	CHEMBL3739162	Inhibition of PKD2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	13.1	CHEMBL4900	Homo sapiens	INH	%	13.1
	16397425	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	16397426	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	23.0	CHEMBL4900	Homo sapiens	INH	%	23.0
	16397427	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	43.0	CHEMBL4900	Homo sapiens	INH	%	43.0
	16397428	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	56.0	CHEMBL4900	Homo sapiens	INH	%	56.0
	16397429	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	78.0	CHEMBL4900	Homo sapiens	INH	%	78.0
	16397430	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	98.0	CHEMBL4900	Homo sapiens	INH	%	98.0
	16397431	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	65.0	CHEMBL4900	Homo sapiens	INH	%	65.0
	16397432	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	65.0	CHEMBL4900	Homo sapiens	INH	%	65.0
	16397433	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	67.0	CHEMBL4900	Homo sapiens	INH	%	67.0
	16397434	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	54.0	CHEMBL4900	Homo sapiens	INH	%	54.0
	16397435	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	54.0	CHEMBL4900	Homo sapiens	INH	%	54.0
	16397436	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	45.0	CHEMBL4900	Homo sapiens	INH	%	45.0
	16397437	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	67.0	CHEMBL4900	Homo sapiens	INH	%	67.0
	16397438	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	32.0	CHEMBL4900	Homo sapiens	INH	%	32.0
	16397439	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	64.0	CHEMBL4900	Homo sapiens	INH	%	64.0
	16397440	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	45.0	CHEMBL4900	Homo sapiens	INH	%	45.0
	16397441	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	68.0	CHEMBL4900	Homo sapiens	INH	%	68.0
	16397442	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	76.0	CHEMBL4900	Homo sapiens	INH	%	76.0
	16397443	CHEMBL3743117	Inhibition of PKD2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	54.0	CHEMBL4900	Homo sapiens	INH	%	54.0
	16413498	CHEMBL3742682	Inhibition of PKD2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	uM	10.0
	16431973	CHEMBL3750012	Inhibition of human PKD2 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	uM	10.0
	16445234	CHEMBL3755579	Inhibition of PRKD2 (unknown origin) assessed as enzyme activity at 5 uM	B	Cc1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL3754770	=	Activity	%	14.0	CHEMBL4900	Homo sapiens	Activity	%	14.0
	16445242	CHEMBL3755767	Inhibition of PRKD2 (unknown origin) assessed as enzyme activity at 10 uM	B	Brc1c(Br)c(Br)c2[nH]cnc2c1Br		CHEMBL373937	=	Activity	%	5.0	CHEMBL4900	Homo sapiens	Activity	%	5.0
	16451581	CHEMBL3760878	Inhibition of PKD2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	7.8	CHEMBL4900	Homo sapiens	INH	%	7.8
	16495193	CHEMBL3777521	Inhibition of N-terminal His6-tagged recombinant human PDK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-33.0	CHEMBL4900	Homo sapiens	Activity	%	-33.0
	16496112	CHEMBL3777521	Inhibition of N-terminal His6-tagged recombinant human PDK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-13.0	CHEMBL4900	Homo sapiens	Activity	%	-13.0
Not Active	16506517	CHEMBL3776512	Inhibition of full length recombinant human GST-tagged PRKD2 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	16506518	CHEMBL3776513	Inhibition of full length recombinant human GST-tagged PRKD2 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	19.0	CHEMBL4900	Homo sapiens	INH	%	19.0
	16508902	CHEMBL3777521	Inhibition of N-terminal His6-tagged recombinant human PDK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL4900	Homo sapiens	Activity	%	3.0
	16559754	CHEMBL3794949	Inhibition of full length human N-terminal GST-tagged PKD2 (1 to 878 residues) expressed in baculovirus expression system using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	1.3	CHEMBL4900	Homo sapiens	INH	%	1.3
	16559755	CHEMBL3794949	Inhibition of full length human N-terminal GST-tagged PKD2 (1 to 878 residues) expressed in baculovirus expression system using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	5.7	CHEMBL4900	Homo sapiens	INH	%	5.7
	16559756	CHEMBL3794949	Inhibition of full length human N-terminal GST-tagged PKD2 (1 to 878 residues) expressed in baculovirus expression system using fluorescence labelled GS peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	4.5	CHEMBL4900	Homo sapiens	INH	%	4.5
	16578407	CHEMBL3802467	Inhibition of partial length wild type human PRKD2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	88.0	CHEMBL4900	Homo sapiens	Activity	%	88.0
	16593522	CHEMBL3811357	Inhibition of GST-tagged full length human recombinant PKD2 expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4900	Homo sapiens	INH	%	40.0
	16614603	CHEMBL3815959	Inhibition of human PKD2 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	4.0	CHEMBL4900	Homo sapiens	INH	%	4.0
	16618119	CHEMBL3816505	Inhibition of full length recombinant human GST-tagged PKD2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	16896903	CHEMBL3882374	Inhibition of human PKD2 assessed as residual activity using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	Cc1ccc(N/C=C2\C(=O)CCc3c2oc2c(Cl)c(Cl)c(O)cc32)cc1		CHEMBL3920024	=	Activity	%	20.9	CHEMBL4900	Homo sapiens	Activity	%	20.9
Inactive	17931181	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931182	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931183	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931184	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931185	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931186	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	1117.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1117.0
Inactive	17931187	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931188	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931189	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931190	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931191	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931192	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931193	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	474.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	474.0
Active	17931194	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1939.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1939.0
Active	17931195	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	46.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	46.0
Inactive	17931196	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931197	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931198	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931199	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931200	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931201	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	1207.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1207.0
Inactive	17931202	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931203	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931204	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931205	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931206	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931207	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931208	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931209	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931210	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931211	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931212	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2232.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2232.0
Active	17931213	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	Kd	nM	25019.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	25019.0
Inactive	17931214	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931215	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Kd	nM	6416.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	6416.0
Inactive	17931216	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931217	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931218	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	244.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	244.0
Inactive	17931219	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931220	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931221	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931222	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931223	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931224	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931225	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931226	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931227	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931228	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	1188.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1188.0
Inactive	17931229	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931230	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931231	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931232	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931233	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931234	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931235	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931236	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931237	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931238	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931239	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931240	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931241	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931242	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931243	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	=	Kd	nM	6336.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	6336.0
Inactive	17931244	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931245	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931246	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931247	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931248	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931249	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931250	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931251	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931252	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931253	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931254	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931255	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931256	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931257	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931258	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	140.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	140.0
Inactive	17931259	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931260	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	1463.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1463.0
Inactive	17931261	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931262	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931263	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	6488.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	6488.0
Inactive	17931264	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931265	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931266	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	1367.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1367.0
Inactive	17931267	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931268	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	3.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	3.0
Inactive	17931269	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931270	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931271	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931272	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931273	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931274	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931275	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	56.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	56.0
Inactive	17931276	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931277	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931278	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931279	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931280	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931281	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931282	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931283	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931284	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931285	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931286	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931287	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931288	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931289	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931290	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931291	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	5673.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	5673.0
Inactive	17931292	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931293	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931294	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931295	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931296	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931297	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931298	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931299	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931300	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931301	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931302	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931303	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	928.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	928.0
Inactive	17931304	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931305	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	244.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	244.0
Inactive	17931306	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931307	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931308	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931309	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931310	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	4236.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	4236.0
Inactive	17931311	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931312	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931313	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931314	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	572.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	572.0
Inactive	17931315	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931316	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931317	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931318	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931319	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931320	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931321	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	69.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	69.0
Inactive	17931322	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931323	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931324	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	34.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	34.0
Inactive	17931325	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931326	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931327	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931328	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931329	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931330	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931331	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	66852.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	66852.0
Active	17931332	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1316.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1316.0
Inactive	17931333	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931334	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931335	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931336	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931337	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931338	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931339	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931340	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931341	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931342	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	2670.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2670.0
Inactive	17931343	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931344	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931345	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931346	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931347	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931348	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931349	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931350	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931351	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931352	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	2064.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2064.0
Inactive	17931353	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931354	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931355	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931356	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931357	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931358	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931359	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931360	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931361	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931362	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931363	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	531.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	531.0
Inactive	17931364	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931365	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931366	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931367	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	195.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	195.0
Inactive	17931368	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931369	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931370	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931371	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931372	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931373	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931374	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931375	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931376	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	30.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30.0
Active	17931377	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	6411.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	6411.0
Inactive	17931378	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931379	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931380	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931381	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931382	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931383	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	143.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	143.0
Inactive	17931384	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931385	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	2246.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2246.0
Inactive	17931386	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931387	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	103.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	103.0
Inactive	17931388	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931389	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931390	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931391	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931392	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931393	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931394	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931395	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931396	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1125.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1125.0
Inactive	17931397	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931398	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931399	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	2080.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2080.0
Active	17931400	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	=	Kd	nM	2541.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2541.0
Inactive	17931401	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931402	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Kd	nM	5623.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	5623.0
Active	17931403	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	2314.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	2314.0
Inactive	17931404	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931405	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931406	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931407	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	3703.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	3703.0
Active	17931408	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	1161.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	1161.0
Inactive	17931409	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931410	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931411	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931412	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931413	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931414	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	10389.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	10389.0
Inactive	17931415	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931416	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Active	17931417	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	=	Kd	nM	3911.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	3911.0
Inactive	17931418	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931419	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931420	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931421	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931422	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931423	CHEMBL3991849	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4900	Homo sapiens	Kd apparent	nM	30000.0
	17982181	CHEMBL3998818	Inhibition of human PKD2 using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL4900	Homo sapiens	INH	%	80.0
	18052928	CHEMBL4011940	Inhibition of PKD2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	0.3	CHEMBL4900	Homo sapiens	INH	%	0.3
	18114814	CHEMBL4025344	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	18143857	CHEMBL4031847	Inhibition of PKD2 in human PBMC at 1 uM	B	Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1		CHEMBL3961632	>	Inhibition	%	35.0	CHEMBL4900	Homo sapiens	INH	%	35.0
	18153042	CHEMBL4034464	Inhibition of PKD2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	1.1	CHEMBL4900	Homo sapiens	INH	%	1.1
	18153237	CHEMBL4034465	Inhibition of PKD2 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	11.5	CHEMBL4900	Homo sapiens	INH	%	11.5
	18203868	CHEMBL4044155	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	98.0	CHEMBL4900	Homo sapiens	Activity	%	98.0
	18211712	CHEMBL4045808	Inhibition of PKD2 conserved Lys1 (DVAVKVIDK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-16.7	CHEMBL4900	Homo sapiens	INH	%	-16.7
	18211953	CHEMBL4046049	Inhibition of PKD2 conserved Lys1 (DVAVKVIDK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-40.0	CHEMBL4900	Homo sapiens	INH	%	-40.0
	18253927	CHEMBL4055248	Inhibition of wild-type human partial length PKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	18253928	CHEMBL4055248	Inhibition of wild-type human partial length PKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	18275383	CHEMBL4118517	Inhibition of human PRKD2 (519 to 838 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	72.0	CHEMBL4900	Homo sapiens	Activity	%	72.0
Active	18275782	CHEMBL4118742	Binding affinity to PRKD2 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4900	Homo sapiens	Activity		
Active	18275933	CHEMBL4118893	Binding affinity to PRKD2 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4900	Homo sapiens	Activity		
	18276155	CHEMBL4119085	Inhibition of human PRKD2 (519 to 838 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	2.5	CHEMBL4900	Homo sapiens	Activity	%	2.5
	18282669	CHEMBL4120254	Inhibition of PKD2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.7	CHEMBL4900	Homo sapiens	INH	%	6.7
	18282885	CHEMBL4120470	Inhibition of PKD2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	9.0	CHEMBL4900	Homo sapiens	INH	%	9.0
	18283099	CHEMBL4120684	Inhibition of PKD2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	9.3	CHEMBL4900	Homo sapiens	INH	%	9.3
	18440410	CHEMBL4157234	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL4900	Homo sapiens	Activity	%	98.0
	18463795	CHEMBL4181211	Inhibition of recombinant human full length N-terminal His6-tagged PKD2 expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	11.0	CHEMBL4900	Homo sapiens	INH	%	11.0
	18484366	CHEMBL4186013	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	98.0	CHEMBL4900	Homo sapiens	Activity	%	98.0
	18484850	CHEMBL4186013	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	98.0	CHEMBL4900	Homo sapiens	Activity	%	98.0
	18507643	CHEMBL4191148	Inhibition of recombinant full-length human PKD2 at 1 uM using KKLNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	18653405	CHEMBL4230203	Inhibition of PRKD2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL4900	Homo sapiens	INH	%	1.0
	18653406	CHEMBL4230203	Inhibition of PRKD2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL4900	Homo sapiens	INH	%	2.0
	18655322	CHEMBL4230913	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	93.0	CHEMBL4900	Homo sapiens	Activity	%	93.0
	18665517	CHEMBL4233393	Inhibition of PRKD2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4900	Homo sapiens	IC50	nM	1000.0
	18674863	CHEMBL4235423	Inhibition of PRKD2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	1000.0	CHEMBL4900	Homo sapiens	Ki	nM	1000.0
	18674864	CHEMBL4235423	Inhibition of PRKD2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4900	Homo sapiens	Ki	nM	2000.0
Not Determined	18674865	CHEMBL4235423	Inhibition of PRKD2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL4900	Homo sapiens	Ki		
	18751217	CHEMBL4263926	Inhibition of PRKD2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4900	Homo sapiens	INH	%	3.0
	18752165	CHEMBL4264502	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	70.0	CHEMBL4900	Homo sapiens	Activity	%	70.0
	18858165	CHEMBL4308011	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL4900	Homo sapiens	Activity	%	93.0
	18892697	CHEMBL4314552	Inhibition of recombinant full-length human PKD2 assessed as residual activity at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	120.0	CHEMBL4900	Homo sapiens	Activity	%	120.0
	18919418	CHEMBL4322777	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged PRKD2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	79.0	CHEMBL4900	Homo sapiens	Kd	nM	79.0
	18919606	CHEMBL4322777	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged PRKD2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	140.0	CHEMBL4900	Homo sapiens	Kd	nM	140.0
	18938237	CHEMBL4327845	Inhibition of human PKD2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	104.98	CHEMBL4900	Homo sapiens	Activity	%	104.98
	18938238	CHEMBL4327845	Inhibition of human PKD2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.37	CHEMBL4900	Homo sapiens	Activity	%	96.37
	18938690	CHEMBL4328209	Inhibition of human PKD2 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4900	Homo sapiens	Activity	%	65.0
	18939074	CHEMBL4328573	Inhibition of human PKD2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.33	CHEMBL4900	Homo sapiens	IC50	10'-9M	1.33
	18958595	CHEMBL4333596	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	18964614	CHEMBL4335248	Inhibition of recombinant full-length human PKD2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL4900	Homo sapiens	Activity	%	103.0
	18964615	CHEMBL4335248	Inhibition of recombinant full-length human PKD2 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	99.0	CHEMBL4900	Homo sapiens	Activity	%	99.0
	18972061	CHEMBL4337071	Inhibition of recombinant full-length human PKD2 assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	65.0	CHEMBL4900	Homo sapiens	Activity	%	65.0
	19032209	CHEMBL4349802	Inhibition of PRKD2 (unknown origin) at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-8.0	CHEMBL4900	Homo sapiens	INH	%	-8.0
Not Active	19040119	CHEMBL4352022	Inhibition of recombinant full-length human PKD2 at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	19041251	CHEMBL4352512	Inhibition of human PKD2 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	19059790	CHEMBL4358091	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	99.0	CHEMBL4900	Homo sapiens	Activity	%	99.0
	19090354	CHEMBL4365928	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	93.0	CHEMBL4900	Homo sapiens	Activity	%	93.0
	19092083	CHEMBL4366557	Inhibition of human PKD2 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-3.61	CHEMBL4900	Homo sapiens	INH	%	-3.61
	19144808	CHEMBL4377824	Inhibition of recombinant full-length human PKD2 at 1 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-6.0	CHEMBL4900	Homo sapiens	INH	%	-6.0
	19146933	CHEMBL4378859	Inhibition of full-length recombinant human PKD2 at 10 uM using KKLNRTLSVA as substrate after 40 mins by in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-4.0	CHEMBL4900	Homo sapiens	INH	%	-4.0
	19148005	CHEMBL4379225	Inhibition of recombinant full-length human PKD2 using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4900	Homo sapiens	IC50	uM	10.0
	19159618	CHEMBL4382722	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	3.1	CHEMBL4900	Homo sapiens	Activity	%	3.1
	19191389	CHEMBL4389441	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	85.0	CHEMBL4900	Homo sapiens	INH	%	85.0
	19192104	CHEMBL4389918	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	98.0	CHEMBL4900	Homo sapiens	INH	%	98.0
	19200360	CHEMBL4391544	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	31.0	CHEMBL4900	Homo sapiens	Activity	%	31.0
	19218929	CHEMBL4394544	Binding affinity to wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	<	Kd	nM	225.0	CHEMBL4900	Homo sapiens	Kd	nM	225.0
	19266578	CHEMBL4405528	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4900	Homo sapiens	INH	%	50.0
	19276083	CHEMBL4408086	Inhibition of recombinant human full length PKD2 at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	17.0	CHEMBL4900	Homo sapiens	INH	%	17.0
	20600649	CHEMBL4603601	Inhibition of recombinant full length human GST-tagged PRKD2 expressed in baculovirus expression system using serine/threonine-01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4900	Homo sapiens	IC50	uM	100.0
	20665598	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Nc1ccc(-c2cc(NC3CCCNC3)c3ccncc3c2)cc1		CHEMBL4646995	=	IC50	nM	246.0	CHEMBL4900	Homo sapiens	IC50	uM	0.246
	20665599	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Nc1cccc(-c2cc(NC3CCCNC3)c3ccncc3c2)c1		CHEMBL4640042	=	IC50	nM	102.0	CHEMBL4900	Homo sapiens	IC50	uM	0.102
	20665600	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Nc1ccccc1-c1cc(NC2CCCNC2)c2ccncc2c1		CHEMBL4645229	=	IC50	nM	187.0	CHEMBL4900	Homo sapiens	IC50	uM	0.187
	20665601	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Oc1ccc(-c2cc(NC3CCCNC3)c3ccncc3c2)cc1		CHEMBL4644939	=	IC50	nM	17.0	CHEMBL4900	Homo sapiens	IC50	uM	0.017
	20665602	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Oc1ccccc1-c1cc(NC2CCCNC2)c2ccncc2c1		CHEMBL4648006	=	IC50	nM	263.0	CHEMBL4900	Homo sapiens	IC50	uM	0.263
	20665603	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	c1ccc(-c2cc(NC3CCCNC3)c3ccncc3c2)cc1		CHEMBL4641918	=	IC50	nM	261.0	CHEMBL4900	Homo sapiens	IC50	uM	0.261
	20665604	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	CC(=O)Nc1ccc(-c2cc(NC3CCCNC3)c3ccncc3c2)cc1		CHEMBL4642061	=	IC50	nM	762.0	CHEMBL4900	Homo sapiens	IC50	uM	0.762
	20665605	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	c1ccc(-c2cc(N[C@H]3CCCNC3)c3ccncc3c2)cc1		CHEMBL4636488	=	IC50	nM	144.0	CHEMBL4900	Homo sapiens	IC50	uM	0.144
	20665606	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	c1ccc(-c2cc(N[C@@H]3CCCNC3)c3ccncc3c2)cc1		CHEMBL4641607	=	IC50	nM	3315.0	CHEMBL4900	Homo sapiens	IC50	uM	3.315
	20665607	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	NCCNc1cc(-c2ccccc2)cc2cnccc12		CHEMBL4643470	=	IC50	nM	202.0	CHEMBL4900	Homo sapiens	IC50	uM	0.202
	20665608	CHEMBL4619379	Inhibition of PKD2 (unknown origin)	B	Nc1ccc(-c2cc(N[C@H]3CCCCNC3)c3ccncc3c2)cc1		CHEMBL4642166	=	IC50	nM	1187.0	CHEMBL4900	Homo sapiens	IC50	uM	1.187
	22423307	CHEMBL4674229	Inhibition of human PKD2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	79.46	CHEMBL4900	Homo sapiens	Activity	%	79.46
	22423308	CHEMBL4674229	Inhibition of human PKD2 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	4.75	CHEMBL4900	Homo sapiens	Activity	%	4.75
Not Determined	22752715	CHEMBL4700180	Inhibition of human PKD2 at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	22752716	CHEMBL4700180	Inhibition of human PKD2 at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	Inhibition	%	47.0	CHEMBL4900	Homo sapiens	INH	%	47.0
	22843598	CHEMBL4720584	Inhibition of human PKD2 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.48	CHEMBL4900	Homo sapiens	IC50	10^-9M	1.48
	22843943	CHEMBL4720929	Inhibition of human PKD2 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	88.7	CHEMBL4900	Homo sapiens	Activity	%	88.7
	22844838	CHEMBL4721513	Inhibition of wild-type human partial length PRKD2 (A519 to E838 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	62.08	CHEMBL4900	Homo sapiens	Activity	%	62.08
	22883481	CHEMBL4727566	Inhibition of recombinant human full-length GST-tagged PRKD2 expressed in baculovirus expression system	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<=	IC50	nM	500.0	CHEMBL4900	Homo sapiens	IC50	nM	500.0
	22952968	CHEMBL4766905	Inhibition of recombinant full-length human PKD2 assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	67.0	CHEMBL4900	Homo sapiens	Activity	%	67.0
	22986591	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(Cc2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4799852	=	Activity	%	48.0	CHEMBL4900	Homo sapiens	Activity	%	48.0
	22986592	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4779081	=	Activity	%	15.0	CHEMBL4900	Homo sapiens	Activity	%	15.0
	22986593	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	20.0	CHEMBL4900	Homo sapiens	Activity	%	20.0
	22986594	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Cn1cc(-c2nn(C(C)(C)C)c3ncnc(N)c23)c2ccccc21		CHEMBL4800579	=	Activity	%	53.0	CHEMBL4900	Homo sapiens	Activity	%	53.0
	22986595	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	COc1ccc2[nH]cc(-c3nn(C(C)(C)C)c4ncnc(N)c34)c2c1		CHEMBL4778679	=	Activity	%	96.0	CHEMBL4900	Homo sapiens	Activity	%	96.0
	22986596	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2c[nH]c3ccc(F)cc23)c2c(N)ncnc21		CHEMBL4790094	=	Activity	%	82.0	CHEMBL4900	Homo sapiens	Activity	%	82.0
	22986597	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2c[nH]c3cc(F)ccc23)c2c(N)ncnc21		CHEMBL4785996	=	Activity	%	72.0	CHEMBL4900	Homo sapiens	Activity	%	72.0
	22986598	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2c[nH]c3cc(Cl)ccc23)c2c(N)ncnc21		CHEMBL4778046	=	Activity	%	97.0	CHEMBL4900	Homo sapiens	Activity	%	97.0
	22986599	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2cc[nH]c2)c2c(N)ncnc21		CHEMBL4780246	=	Activity	%	68.0	CHEMBL4900	Homo sapiens	Activity	%	68.0
	22986600	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2cn[nH]c2)c2c(N)ncnc21		CHEMBL4779416	=	Activity	%	94.0	CHEMBL4900	Homo sapiens	Activity	%	94.0
	22986601	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2c[nH]c3cccnc23)c2c(N)ncnc21		CHEMBL4778331	=	Activity	%	25.0	CHEMBL4900	Homo sapiens	Activity	%	25.0
	22986602	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)n1nc(-c2cccc3ncccc23)c2c(N)ncnc21		CHEMBL4779371	=	Activity	%	82.0	CHEMBL4900	Homo sapiens	Activity	%	82.0
	22986603	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4783728	=	Activity	%	25.0	CHEMBL4900	Homo sapiens	Activity	%	25.0
	22986604	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(C)CCn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4780880	=	Activity	%	93.0	CHEMBL4900	Homo sapiens	Activity	%	93.0
	22986605	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCCC1		CHEMBL4798416	=	Activity	%	43.0	CHEMBL4900	Homo sapiens	Activity	%	43.0
	22986606	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCCCC1		CHEMBL4789808	=	Activity	%	92.0	CHEMBL4900	Homo sapiens	Activity	%	92.0
	22986607	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC12CC3CC(CC(C3)C1)C2		CHEMBL4788131	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	22986608	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2Cc1ccccc1		CHEMBL4798297	=	Activity	%	68.0	CHEMBL4900	Homo sapiens	Activity	%	68.0
	22986609	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CCc1ccccc1		CHEMBL4794923	=	Activity	%	69.0	CHEMBL4900	Homo sapiens	Activity	%	69.0
	22986610	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC#Cc1ccccc1		CHEMBL4798985	=	Activity	%	100.0	CHEMBL4900	Homo sapiens	Activity	%	100.0
	22986611	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2Cc1cccc2ccccc12		CHEMBL4779893	=	Activity	%	96.0	CHEMBL4900	Homo sapiens	Activity	%	96.0
	22986612	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCOCC1		CHEMBL4795484	=	Activity	%	46.0	CHEMBL4900	Homo sapiens	Activity	%	46.0
	22986613	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(=O)N1CCC(Cn2nc(-c3c[nH]c4ccccc34)c3c(N)ncnc32)CC1		CHEMBL4789563	=	Activity	%	44.0	CHEMBL4900	Homo sapiens	Activity	%	44.0
	22986614	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572	=	Activity	%	5.0	CHEMBL4900	Homo sapiens	Activity	%	5.0
	22986615	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	Nc1ncnc2c1c(-c1cccc3ccccc13)nn2CC1CCNCC1		CHEMBL4776166	=	Activity	%	19.0	CHEMBL4900	Homo sapiens	Activity	%	19.0
	22986616	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(CO)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4790321	=	Activity	%	4.0	CHEMBL4900	Homo sapiens	Activity	%	4.0
	22986617	CHEMBL4774308	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells assessed as residual activity at 1 uM using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay relative to control	B	CC(C)(CO)Cn1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL4785578	=	Activity	%	27.0	CHEMBL4900	Homo sapiens	Activity	%	27.0
	22986627	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	786.0	CHEMBL4900	Homo sapiens	IC50	nM	786.0
	22986628	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4779081	=	IC50	nM	94.0	CHEMBL4900	Homo sapiens	IC50	nM	94.0
	22986629	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Cn1cc(-c2nn(C(C)(C)C)c3ncnc(N)c23)c2ccccc21		CHEMBL4800579	=	IC50	nM	3286.0	CHEMBL4900	Homo sapiens	IC50	nM	3286.0
	22986630	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(-c2c[nH]c3cccnc23)c2c(N)ncnc21		CHEMBL4778331	=	IC50	nM	282.0	CHEMBL4900	Homo sapiens	IC50	nM	282.0
	22986631	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572	=	IC50	nM	35.0	CHEMBL4900	Homo sapiens	IC50	nM	35.0
	22986632	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Nc1ncnc2c1c(-c1cccc3ccccc13)nn2CC1CCNCC1		CHEMBL4776166	=	IC50	nM	55.0	CHEMBL4900	Homo sapiens	IC50	nM	55.0
	22986633	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(CO)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4790321	=	IC50	nM	43.0	CHEMBL4900	Homo sapiens	IC50	nM	43.0
	22986634	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1		CHEMBL4515390	=	IC50	nM	9.0	CHEMBL4900	Homo sapiens	IC50	nM	9.0
	22986635	CHEMBL4774310	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2n1		CHEMBL4576165	=	IC50	nM	48.0	CHEMBL4900	Homo sapiens	IC50	nM	48.0
	22986646	CHEMBL4774313	Potency index, ratio of 3-IN-PP1 IC50 to test compound IC50 for inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in HEK293T cells	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572	=	Ratio IC50		3.0	CHEMBL4900	Homo sapiens	Ratio IC50		3.0
Active	22986652	CHEMBL4774316	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	22986653	CHEMBL4774316	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4779081		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	22986654	CHEMBL4774316	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
Active	22986655	CHEMBL4774316	Inhibition of recombinant FLAG-tagged PKD2 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1		CHEMBL4515390		Inhibition	%		CHEMBL4900	Homo sapiens	INH		
	23122775	CHEMBL4805126	Inhibition of human PRKD2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	88.0	CHEMBL4900	Homo sapiens	Activity	%	88.0
	23123470	CHEMBL4805714	Inhibition of human PRKD2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	64.0	CHEMBL4900	Homo sapiens	Activity	%	64.0
	23123925	CHEMBL4806169	Inhibition of DNA-tagged human PRKD2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	87.0	CHEMBL4900	Homo sapiens	Activity	%	87.0
	23125030	CHEMBL4806731	Inhibition of human PRKD2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	56.0	CHEMBL4900	Homo sapiens	Activity	%	56.0
	23125031	CHEMBL4806731	Inhibition of human PRKD2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	90.0	CHEMBL4900	Homo sapiens	Activity	%	90.0
	23128503	CHEMBL4807976	Inhibition of PRKD2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4900	Homo sapiens	Activity	%	75.0
	23128504	CHEMBL4807976	Inhibition of PRKD2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4900	Homo sapiens	Activity	%	75.0
	23128505	CHEMBL4807976	Inhibition of PRKD2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4900	Homo sapiens	Activity	%	75.0
	23213440	CHEMBL4822974	Inhibition of human recombinant PKD2 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	11.0	CHEMBL4900	Homo sapiens	INH	%	11.0
Not Active	23317611	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	99.0	CHEMBL4900	Homo sapiens	% Control	%	99.0
Not Active	23318079	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23318745	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	84.0	CHEMBL4900	Homo sapiens	% Control	%	84.0
Not Active	23319229	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23319866	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23320341	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	90.6	CHEMBL4900	Homo sapiens	% Control	%	90.6
Not Active	23321019	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	91.0	CHEMBL4900	Homo sapiens	% Control	%	91.0
Not Active	23321487	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23322117	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL4900	Homo sapiens	% Control	%	84.0
Not Active	23322585	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23323274	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23323742	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23324109	CHEMBL4880728	PKD2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	3.0	CHEMBL4900	Homo sapiens	% inhibition	%	3.0
Not Active	23324596	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23325231	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	73.0	CHEMBL4900	Homo sapiens	% Control	%	73.0
Not Active	23325699	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	73.0	CHEMBL4900	Homo sapiens	% Control	%	73.0
Not Active	23326346	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	85.0	CHEMBL4900	Homo sapiens	% Control	%	85.0
Not Active	23326814	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	87.0	CHEMBL4900	Homo sapiens	% Control	%	87.0
Not Active	23327514	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL4900	Homo sapiens	% Control	%	98.0
Not Active	23327982	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	90.0	CHEMBL4900	Homo sapiens	% Control	%	90.0
Not Active	23328569	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23329037	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23329491	CHEMBL4881198	PKD2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	106.0	CHEMBL4900	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23329983	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23330451	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	92.0	CHEMBL4900	Homo sapiens	% Control	%	92.0
Not Active	23331207	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23331675	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23332262	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23332728	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23333446	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	98.8	CHEMBL4900	Homo sapiens	% Control	%	98.8
Not Active	23334085	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23334553	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL4900	Homo sapiens	% Control	%	99.0
Not Active	23334947	CHEMBL4881569	PKD2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	28.0	CHEMBL4900	Homo sapiens	% inhibition	%	28.0
Not Active	23335532	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	94.0	CHEMBL4900	Homo sapiens	% Control	%	94.0
Not Active	23336000	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	91.0	CHEMBL4900	Homo sapiens	% Control	%	91.0
Not Active	23336627	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	85.0	CHEMBL4900	Homo sapiens	% Control	%	85.0
Not Active	23337095	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL4900	Homo sapiens	% Control	%	92.0
Not Active	23337746	CHEMBL4882117	PRKD2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.0	CHEMBL4900	Homo sapiens	% Ctrl	%	95.0
Not Active	23338176	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23338644	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL4900	Homo sapiens	% Control	%	89.0
Not Active	23339256	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	96.0	CHEMBL4900	Homo sapiens	% Control	%	96.0
Not Active	23339724	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	89.0	CHEMBL4900	Homo sapiens	% Control	%	89.0
Not Active	23340361	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	97.0	CHEMBL4900	Homo sapiens	% Control	%	97.0
Not Active	23340829	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	94.0	CHEMBL4900	Homo sapiens	% Control	%	94.0
Not Active	23341486	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23341954	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23342570	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23343038	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23343668	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23344136	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23344774	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23345347	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	95.0	CHEMBL4900	Homo sapiens	% Control	%	95.0
Not Active	23345815	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23346392	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	96.1	CHEMBL4900	Homo sapiens	% Control	%	96.1
Not Active	23346860	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23347462	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	97.5	CHEMBL4900	Homo sapiens	% Control	%	97.5
Not Active	23347952	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23348531	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23348999	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	88.0	CHEMBL4900	Homo sapiens	% Control	%	88.0
Not Active	23349586	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	79.0	CHEMBL4900	Homo sapiens	% Control	%	79.0
Not Active	23350204	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23350672	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	86.0	CHEMBL4900	Homo sapiens	% Control	%	86.0
Not Active	23351277	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23351745	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23352199	CHEMBL4882888	PRKD2 (PKD2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	19.01	CHEMBL4900	Homo sapiens	% Inhibition	%	19.0117
Not Active	23352769	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23353237	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	90.0	CHEMBL4900	Homo sapiens	% Control	%	90.0
Not Active	23354119	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23354587	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23355319	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23355787	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23356423	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23356891	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23357500	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23358147	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	94.0	CHEMBL4900	Homo sapiens	% Control	%	94.0
Not Active	23358615	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23359201	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23359799	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	58.0	CHEMBL4900	Homo sapiens	% Control	%	58.0
Not Active	23360267	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	91.0	CHEMBL4900	Homo sapiens	% Control	%	91.0
Not Active	23360852	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL4900	Homo sapiens	% Control	%	95.0
Not Active	23361320	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23361893	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	79.0	CHEMBL4900	Homo sapiens	% Control	%	79.0
Not Active	23362429	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4900	Homo sapiens	% Control	%	94.0
Not Active	23362897	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	76.0	CHEMBL4900	Homo sapiens	% Control	%	76.0
Not Active	23364539	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23365007	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23365746	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	84.0	CHEMBL4900	Homo sapiens	% Control	%	84.0
Not Active	23366289	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	97.0	CHEMBL4900	Homo sapiens	% Control	%	97.0
Not Active	23366879	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23367347	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23367718	CHEMBL4884071	PRKD2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	85.0	CHEMBL4900	Homo sapiens	% Residual activity with Skepinone-L	%	85.0
Not Active	23368225	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	85.0	CHEMBL4900	Homo sapiens	% Control	%	85.0
Not Active	23368693	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23369292	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23369760	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	84.0	CHEMBL4900	Homo sapiens	% Control	%	84.0
Not Active	23370207	CHEMBL4884449	PKD2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	98.0	CHEMBL4900	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23370728	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	87.0	CHEMBL4900	Homo sapiens	% Control	%	87.0
Not Active	23371196	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	95.0	CHEMBL4900	Homo sapiens	% Control	%	95.0
Not Active	23372005	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23372473	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	92.0	CHEMBL4900	Homo sapiens	% Control	%	92.0
	23372868	CHEMBL4884833	PKD2(PRD2LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4900	Homo sapiens	pIC50		6.0
	23373277	CHEMBL4885124	PKD2(PRD2LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4900	Homo sapiens	pIC50		6.0
	23373633	CHEMBL4885410	PKD2(PRD2LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4900	Homo sapiens	pIC50		6.0
Not Active	23375353	CHEMBL4886335	protein kinase D2  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	2.0	CHEMBL4900	Homo sapiens	% inhibition	%	2.0
Not Active	23375900	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	85.0	CHEMBL4900	Homo sapiens	% Control	%	85.0
Not Active	23376368	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23376945	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	97.0	CHEMBL4900	Homo sapiens	% Control	%	97.0
Not Active	23377413	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	96.0	CHEMBL4900	Homo sapiens	% Control	%	96.0
Not Active	23378273	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23378741	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23379908	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	99.0	CHEMBL4900	Homo sapiens	% Control	%	99.0
Not Active	23380376	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	85.0	CHEMBL4900	Homo sapiens	% Control	%	85.0
Not Active	23381070	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	93.0	CHEMBL4900	Homo sapiens	% Control	%	93.0
Not Active	23381718	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23382186	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23382810	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4900	Homo sapiens	% Control	%	100.0
Not Active	23383278	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	92.0	CHEMBL4900	Homo sapiens	% Control	%	92.0
Not Active	23383959	CHEMBL4887566	PRKD2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL4900	Homo sapiens	% Ctrl	%	95.0
Not Active	23384428	CHEMBL4888023	PKD2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	4.37	CHEMBL4900	Homo sapiens	% inhibition	%	4.37
Not Active	23384700	CHEMBL4888226	PRKD2 (PKD2) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	5.0	CHEMBL4900	Homo sapiens	% Inhibition	%	5.0
Not Active	23385193	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	83.0	CHEMBL4900	Homo sapiens	% Control	%	83.0
Not Active	23385660	CHEMBL4879917	KinomeScan assay: inhibition of PRKD2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	86.0	CHEMBL4900	Homo sapiens	% Control	%	86.0
